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ABSTRACT
HLA-linked haemochromatosis is the result of an 
inborn error of metabolism inherited as an autosomal 
recessive gene, closely linked to the HLA locus on 
chromosome six. In this condition iron absorption is 
inappropriately high leading to iron overload. Integral to 
the pathogenesis of this disorder and in contrast to other 
causes of iron overload, is the relatively modest 
accumulation of iron within cells of both the small 
intestine and the reticuloendothelial system and the 
excessive deposition of iron in parenchymal cells of the 
liver and other organs. This observation has led to the 
suggestion that the primary defect(s) could be present in 
either the gut, the liver, the reticuloendothelial system 
or all three. Abnormalities in iron uptake by cells, iron 
transport through and between cells and iron storage in 
cells have all been suggested as possible mechanisms 
responsible for the abnormal absorption and distribution 
of iron in haemochromatosis. Malfunction of the iron 
transport protein transferrin or its receptor could be 
responsible for abnormal distribution and iron loading 
while an abnormality of ferritin iron storage could 
explain why some cells appear to be unable to store iron 
and others are iron overloaded. Major advances have 
recently been made in our understanding of both ferritin 
synthesis and transferrin receptor expression. It is now 
known that when cellular iron levels are low, ferritin
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synthesis and iron storage decrease, while transferrin 
receptor synthesis and iron uptake increase. Conversely, 
iron in excess of cellular requirements results in an 
increase in ferritin synthesis and a decrease in trans­
ferrin receptors. This regulation occurs at the level of 
mRNA translation, mediated by the interaction of iron 
regulatory proteins and iron responsive elements on the 
respective mRNAs. Despite considerable study of the 
molecular basis underlying the reciprocal and coordinated 
regulation of iron transport into cells and iron storage, 
little is known about the mechanisms by which cells 
release iron.
This study evaluates certain aspects of iron meta­
bolism in relation to the macrophage in hereditary 
haemochromatosis. Macrophages cultured for 8 days in vitro 
were first assessed for viability by trypan blue dye 
exclusion, tritiated uridine and tritiated leucine incor­
poration into RNA and protein, respectively. These experi­
ments revealed that the cells from both normal subjects 
and patients with hereditary haemochromatosis remained 
metabolically viable after 8 days in culture.
A study was done to evaluate the uptake of trans­
ferrin and transferrin iron by 8 day cultured macrophages 
obtained from normal subjects and treated haemochromatotic 
patients. A 1.9 fold and 1.4 fold increase in transferrin 
uptake by haemochromatotic cells over normal cells was 
noted at 1 hour (p = 0.003) and at 1.5 hours (p = 0.009), 
respectively. However, iron uptake by haemochromatotic
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macrophages was 2.7 times lower at two hours (p = 0.01) 
and 2.1 times lower at five hours (p = 0.006) than normal 
macrophages. The results suggest an increased transferrin 
receptor expression in macrophages from patients with 
haemochromatosis. The failure of iron uptake to parallel 
transferrin uptake in haemochromatotic cells could 
represent an inability to sequester iron in the storage 
protein ferritin or an increased cellular iron release by 
some other unknown mechanism.
In the next study, RNA was extracted at various time 
intervals from normal and haemochromatotic macrophages 
cultured in the presence of ferric iron. The RNA was 
probed for H- and L-ferritin subunit mRNA with S-actin 
acting as a constitutively expressed control. Although the 
levels of H-and L-ferritin mRNA relative to E-actin in­
creased in both study groups, the increase in ferritin 
subunit mRNAs was about 4 to 5 fold in normal macrophages 
while in haemochromatotic macrophages a 1.5 to 2 fold 
increase was observed after six hours. The regulation of 
ferritin synthesis by iron is known to occur at both 
transcriptional and translational levels. The greater 
increase in ferritin subunit mRNAs observed in normal 
macrophages suggests that, in haemochromatotic macro­
phages, the mechanism of iron-induced mRNA expression may 
be impaired by changes in either transcription or 
translation. Alternatively, the decreased ferritin 
expression may occur as a secondary event in response to 
lower intracellular iron, possibly caused by accelerated
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release of iron from haemochromatotic cells.
In summary, the findings of these investigations 
suggest that the paucity of iron within reticulo­
endothelial cells in haemochromatosis may result from a 
primary defect in ferritin mRNA expression or alterna­
tively from a secondary decrease in cellular iron storage 
because of enhanced iron release. These experiments were 
conducted on a small number of patients and were confined 
to specific steps in cellular iron metabolism. Further 
work, using more patients and studying the distribution of 
free to polysome-bound mRNA, the rate of ferritin mRNA 
turnover and the amount of the final protein product, 
ferritin, would be required in order to fully address 
ferritin synthesis in haemochromatotic macrophages.
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SECTION 1
CHAPTER 1
INTRODUCTION
1
1.1 GENERAL INTRODUCTION
HLA-linked (idiopathic, genetic, hereditary, primary) 
haemochromatosis is an iron storage disorder in which 
there is an increase in total body iron. The increased 
deposition of the metal in parenchymal cells of the liver, 
heart, pancreas and other organs occurs as a result of 
unexplained excessive mucosal absorption of dietary iron 
and increased release of iron from the reticuloendothelial 
(RE) system. The prolonged presence of large amounts of 
iron within the parenchymal cells eventually results in 
organ dysfunction (Bothwell et al, 1995). A brief de­
scription of some basic concepts of normal iron metabolism 
is required as a background to understanding this disease.
Iron is an essential element required for metabolic 
processes in cells and microorganisms (Crichton and 
Charloteaux-Wauters, 1987). A healthy adult male has 
approximately 3 to 4 grams of body iron (Bothwell et al. 
1979) . The largest portion of body iron is found in the 
functional iron-containing proteins haemoglobin, myo­
globin, haem and non-haem enzymes (Smith, 1990). The iron 
porphyrin complex of haemoglobin and myoglobin serves to 
transport oxygen to cells and to store oxygen within 
tissues, respectively. The various haem enzymes (such as 
cytochromes, catalases, peroxidases) and non-haem iron 
proteins are involved in the electron transport pathway 
and other oxidation and reduction pathways (Pippard and 
Hoffbrand, 1989). Most of the remaining iron (about 0 to 
1 gram depending on the individual's iron status) is found
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in the iron storage protein ferritin and in haemosiderin. 
Ferritin is the main iron store, but in iron overload an 
increasing proportion is found in haemosiderin. Storage 
iron is distributed in the RE cells of the bone marrow, 
liver, spleen and skeletal muscle, mainly as haemosiderin 
and in hepatic parenchymal cells mostly in the form of 
ferritin (Bothwell et al, 1995) . The carrier plasma 
protein transferrin is responsible for ferrying iron 
between these tissues.
Iron exists predominantly in the oxidized state 
(ferric form) which is insoluble and therefore largely 
inaccessible (Bothwell et al, 1979). Much of the dietary 
iron, although plentiful, is unavailable and iron meta­
bolism, in humans, is characterized by conservation of 
body iron achieved by a continuous recycling process. The 
normal plasma iron level is about 3 mg. All of this iron 
is bound to transferrin. About 30 to 40 mg of iron enters 
and leaves the plasma pool per day (Cook et al. 1970; 
Ricketts et al. 1977; Cazzola et al. 1985) . The main­
tenance of this iron pool is effected by internal and 
external iron exchange pathways.
Internal Iron Exchange. Most of the iron entering the 
plasma iron pool is derived from catabolism of erythrocyte 
haemoglobin by RE cells (Morgan, 1981). Other sources of 
plasma iron are derived from storage sites such as the 
liver, muscle and skin and from dietary iron absorbed from 
intestinal mucosal cells and a small amount from the 
extravascular pool. The major flow of iron from plasma is
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delivered to erythropoietic tissue via the transport 
protein, transferrin, for the formation of haemoglobin 
(Morgan, 1981; Huebers and Finch, 1987) . Some of this iron 
entering the erythron is not used for erythropoiesis, but 
is intercepted by the RE cells. The process is termed 
"ineffective" erythropoiesis (Bezkorovainy, 1989) . Plasma 
iron is also exchanged with parenchymal cells of the liver 
and with the extravascular pool (Bothwell et al. 1979) . 
The liver hepatocyte plays a pivotal role in iron meta­
bolism in that it is capable both of releasing iron when 
there is an increased need in other tissues and of taking 
up excess iron when the transferrin saturation (iron­
binding capacity) is increased.
External Iron Exchange. This involves iron gained 
from and lost to the environment. The obligatory daily 
loss of iron in adult males amounts to about 1 mg (Green 
et al, 1968) . This is derived from the gastrointestinal 
and urinary tracts and skin. Iron losses are increased 
through menstruation and pregnancy in females. Require­
ments are also higher during periods of rapid growth in 
infancy and adolescence (Bothwell et al, 1979). To main­
tain the equilibrium, an equal amount to that lost to the 
exterior has to be absorbed from the daily diet. Mucosal 
iron absorption depends largely on the state of body iron 
stores. Iron absorption is decreased when iron stores rise 
and is increased when stores are depleted (Cook et al, 
1974; Walters et al, 1975b; Charlton et al, 1977; Bezwoda 
et al, 1979) . The mechanisms involved in the regulation of 
iron absorption have not yet been clarified.
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1.2 IRON TRANSPORT - TRANSFERRIN
1.2.1 Introduction
The low solubility of ferric ions in physiological 
fluids and the potential toxicity of free iron necessi­
tates the presence of specific iron complexing agents. The 
transferrins are glycoproteins capable of reversibly 
binding iron. These proteins are widely distributed in 
biological fluids ; the three major types comprise the 
serotransferrins (in plasma and extracellular fluid), the 
ovotransferrins (in egg whites) and the lactotransferrins 
(in extracellular secretions and leucocytes) (de Jong et 
al, 1990). The main function of serum transferrin is the 
transport of iron from cells involved in absorption 
(intestinal mucosal cells), storage (hepatocytes and RE 
cells) and erythrocyte catabolism to cells requiring iron 
for their metabolism. Important sites to which transferrin 
delivers iron are the developing erythroid cells of the 
bone marrow and the placenta (Aisen and Brown, 1977). The 
cellular uptake of transferrin-bound iron is brought about 
by specific membrane receptors. The mechanism by which 
cells deliver their iron to transferrin is less clearly 
understood. In the sections that follow the structural 
characteristics of transferrin and the transferrin 
receptor and the regulation of their synthesis in relation 
to iron will be discussed. The uptake of iron from and the 
release of iron to transferrin by cells will also be dealt 
with here.
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1.2.2 Structure
Human transferrin is a beta-1 globulin glycoprotein 
of molecular weight 80 kDa. It consists of a single poly­
peptide chain composed of 679 amino acid residues and two 
N-linked complex glycan chains (Karlsson et al, 1978; Mac- 
Gillivray et al. 1983) . The molecule consists of two homo­
logous domains, an N-terminal domain and a C-terminal 
domain. Each domain is capable of binding one atom of 
Fe(III) and requires the presence of an anion (bicarbonate 
or carbonate) (Bezkorovainy, 1989) . Plasma transferrin is 
normally about one third saturated with iron. Four 
different forms of transferrin, depending on its degree of 
iron saturation, can be distinguished. They are diferric- 
(2 iron atoms bound) , monoferric N- (iron in the N- 
domain), monoferric C- (iron in the C-domain) and apo- 
transferrin (no iron bound) (Makey and Seal, 1976). It has 
been shown that diferric transferrin donates iron more 
efficiently to growing and dividing cells than monoferric 
transferrin (Morgan, 1981; Huebers et al. 1983).
1.2.3 Synthesis
The transferrin gene is located on chromosome 3 at 
q21-25 (Yang et al. 1984) . The major source of plasma 
transferrin is the liver, but other tissues involved in 
the synthesis of this protein are the brain, heart, 
spleen, kidney, muscle and mammary gland (Aldred et al, 
1987; Lee et al, 1987; de Jong et al. 1990) . The synthesis 
of transferrin is inversely related to iron stores. The
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concentration of transferrin is increased in iron defi­
ciency and is decreased in iron overload (Lipschitz et al, 
1974) . The mechanisms of transcriptional and translational 
regulation of transferrin synthesis by iron have not been 
elucidated. However, a number of metal regulatory elements 
have been identified in the promoter region of the gene 
(Adrian et al. 1986; Hamer, 1986; Schaeffer et al, 1989). 
Plasma transferrin concentrations are also increased in 
pregnancy and during oestrogen administration (Bothwell et 
al, 1979) . Furthermore, plasma transferrin levels may fall 
during the acute phase response in various inflammatory 
states, in myocardial infarction and malignant neoplasms 
(Bothwell et al. 1979) .
1.2.4 Use as diagnostic index
Serum transferrin is capable of binding approximately 
60 /imol Fe/1. However, under physiological conditions 
transferrin is only about 30% saturated (Bothwell et al, 
1995) . The serum iron and, more importantly, the satu­
ration of the iron binding capacity gives an indication of 
the iron supply to tissues. The total iron binding 
capacity (TIBC) depends on the concentration of trans­
ferrin and is inversely related to the plasma iron levels. 
In pregnancy and iron deficiency anaemia, the transferrin 
levels increase (and therefore the TIBC) with a con­
comitant drop in the transferrin saturation (Morgan, 
1981), favouring iron transfer from stores to plasma. In 
conditions such as hereditary haemochromatosis, high
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plasma iron levels are associated with a high percentage 
transferrin saturation even before body iron is increased 
(Bassett et al. 1984). It follows that the estimation of
saturation of the serum TIBC is important in assessing 
iron overload, to be discussed in chapter 1.5.4.
1.2.5 Transferrin receptors
1.2.5.1 Introduction
The transfer of iron from transferrin to cells 
involves the binding to specific receptor sites located on 
the cell membrane. Transferrin receptors are present on 
virtually all cell types particularly on dividing, diffe­
rentiating and haemoglobin synthesizing cells (Huebers and 
Finch, 1987; Bothwell et al, 1995). The expression of
transferrin receptors appears to depend on the iron status 
of cells. A process of receptor mediated endocytosis 
facilitates the cellular uptake of iron.
1.2.5.2 Structure
The transferrin receptor is a transmembrane glyco­
protein consisting of two monomers of molecular weight 90 
kDa, linked as a dimer by a disulphide bridge (Omary and 
Trowbridge, 1981; Schneider et al, 1982). Each subunit is 
able to bind one transferrin molecule (Enns and Sussman, 
1981).
1.2.5.3 Synthesis
The gene for the human transferrin receptor is found 
on chromosome 3q21-26 (Miller et al. 1983; Rabin et al,
1985). The primary structure has been determined by
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cloning and sequencing (Kuhn et al, 1984; McClelland et 
al, 1984; Schneider et al. 1984) . The regulation of 
transferrin receptor expression is complex. The number of 
receptors on the cell surface appears to be influenced by 
many factors. There are clear indications that there is a 
strong correlation between cellular proliferation and the 
levels of transferrin receptor expression (Trowbidge and 
Shackelford, 1986) . It is generally high in rapidly pro­
liferating cells. Barnes and Sato (1980) provided further 
evidence that deprivation of tissue culture cells for 
transferrin, or blocking of the transferrin receptor with 
specific monoclonal antibodies (Trowbidge and Lopez, 
1982), leads to inhibition of cellular proliferation. It 
therefore appears that the transferrin receptor is 
involved not only in delivering iron to cells but also 
plays a direct role in the regulation of cell growth, an 
effect that has been difficult to substantiate.
The main factor though controlling the expression of 
transferrin receptors is the intracellular chelatable iron 
pool. Evidence to support this finding was initially pro­
vided by studies in which cells treated with permeant iron 
chelators (Bridges and Cudkowicz, 1984; Testa et al. 1985) 
or grown in iron deficient media (Rudolph et al, 1985), 
resulted in an up-regulation of transferrin receptors. In 
contrast, exposure of a variety of cells to agents that 
supply iron (such as haemin or iron salts) resulted in 
decreased receptor numbers (Testa et al. 1982; Ward et al, 
1982a & b; Ward et al. 1984b). The effects can be accoun­
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ted for by altering the rate of synthesis of the receptors 
(Bomford and Munro, 1985) . A negative feedback is in 
operation : when the available intracellular iron levels 
are low, the number of transferrin receptors increase to 
acquire iron more effectively and when the cells 
accumulate iron, the transferrin receptors decrease to 
limit further iron uptake. This modulation of transferrin 
receptor expression by iron has been confirmed by numerous 
other studies (Louache et al. 1984; Mattia et al, 1984; 
Rao et al, 1985; Muller-Eberhard et al. 1988) . It has 
further been shown that transferrin receptor mRNA levels 
are increased when iron availability is low and decreased 
when iron is plentiful (Mattia et al, 1984; Mullner and 
Kuhn, 1988) . It was demonstrated by Mullner and Kuhn 
(1988) that this effect was due to changes in the sta­
bility of the transferrin receptor mRNA, effected by a 
post-transcriptional mechanism.
The regulation of transferrin receptor expression by 
iron is closely coordinated with the expression of 
ferritin (Harford and Klausner, 1990). In contrast to the 
transferrin receptors, ferritin synthesis is increased 
without a corresponding change in the level of ferritin 
mRNA in the presence of elevated intracellular iron 
concentrations (Zahringer et al. 1976a; Aziz and Munro, 
1986; Rogers and Munro, 1987). The increased synthesis is 
mainly due to an increase in translation of the ferritin 
mRNA, as opposed to a decrease in stability of transferrin 
receptor mRNA observed during iron loading. The molecular
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mechanisms for this coordinate but opposite regulation 
will be fully discussed in chapter 1.3.6 under 'ferritin 
gene regulation and synthesis.'
1.2.6 Transferrin-iron-cell interactions
l.2.6.1 Iron uptake from transferrin
There is now good evidence showing that cells acquire 
iron from transferrin by a process of receptor mediated 
endocytosis. The model has been extensively discussed in 
several reviews (Crichton and Charlotaeux-Wauters, 1987 ; 
Thorstensen and Romslo, 1990; Pollack, 1992; Baker and 
Morgan, 1994) . The mechanism has been demonstrated in 
reticulocytes (Harding et al. 1983), hepatoma cells 
(Dautry-Varsat et al, 1983) and erythroleukaemic cells 
(Klausner et al, 1983) . The process is initiated by
binding of diferric transferrin to the transferrin 
receptor. The interaction between transferrin and its 
receptor is calcium dependent (Hemmaplardh and Morgan,
1977) and maximal at a pH of 7,8 (van Bockxmeer et al,
1978) on reticulocytes. The receptor is concentrated in 
clathrin coated pits. Clathrin is a membrane protein that 
supports receptors for a variety of molecules. The whole 
receptor ligand is internalized by invagination of these 
coated pits to form endocytic vesicles termed endosomes. 
These vesicles are transported along microtubule and 
microfilament tracts by saltatory motion in the cell 
cytoplasm (May and Cuatrecasas, 1985) . The vesicle's lumen 
is rapidly acidified to pH 5,5 by an energy-dependent
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proton pump (van Renswoude et al, 1982) . The acidified 
vesicle is known as the compartment of uncoupling of 
receptor and ligand (CURL) (Goldstein et al. 1979) . The 
low pH facilitates the dissociation of iron from trans­
ferrin. The mechanism by which iron is transferred across 
the membrane of the endosome to the cytoplasm is still 
unclear. Several studies have shown that iron, probably as 
Fe(II), is actively transported across the membrane by a 
membrane-bound protein (Egyed, 1988; Fuchs et al. 1988; 
Morgan, 1988) . It was suggested by Richardson and Baker 
(1992), that a temperature-dependent membrane protein may 
play a role in the transport of iron across the membrane 
of the endocytic vesicle. The apotransferrin-receptor 
complex, unlike other ligand-receptor complexes that are 
completely degraded within lysosomes, remains stable 
within the acidic microenvironment of CURL (Klausner et 
al, 1983) . The iron-free apotransferrin bound to its 
receptor is then recycled back to the cell surface. At the 
extracellular pH of 7,0-7,4 the apotransferrin dissociates 
from the receptor and both molecules can be reutilized 
again.
The process of receptor mediated endocytosis is not 
the only mechanism whereby cells take up iron from trans­
ferrin. Alternative pathways have been demonstrated in 
hepatocytes. These include a receptor mediated endocytic 
pathway effective at low transferrin concentrations in 
combination with non-saturable transferrin binding at high 
transferrin concentrations (Page et al. 1984), fluid phase
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endocytosis (Sibille et al. 1982; Trinder et al. 1986) and 
a non-specific asialoglycoprotein receptor pathway 
(Regoeczi and Koj, 1985).
Finally, although virtually all plasma iron is bound 
to transferrin, a number of compounds including hapto­
globin, haemopexin, ferritin and low molecular weight 
plasma iron complexes constitute the non-transferrin-bound 
iron pool. In patients with marked iron overload, satu­
ration of the binding capacity of transferrin results in 
the presence of higher concentrations of low molecular 
weight iron complexes (Batey et al. 1980; Hershko and
Peto, 1987; Grootveld et al. 1989) and ferritin (Pootrakul 
et al. 1988) in the plasma. Non-transferrin-bound iron is 
potentially toxic and this may play an important role in 
causing the organ damage associated with iron overload.
1.2.6.2 Iron release from cells
To maintain the plasma iron pool the amount of iron 
taken up by cells has to be balanced by an equal amount 
returning to the plasma (Morgan, 1981). The principal 
source of iron is the RE system where phagocytosis of 
senescent red blood cells occurs. The liver, intestinal 
mucosal cells and the extravascular pool also contribute 
to a lesser degree to the plasma iron pool (Morgan, 1981). 
In times of increased demand for iron by the erythron, the 
requirement for transferrin iron is also increased 
(Bothwell et al, 1995) . As a consequence, cells of iron
procurement, particularly RE cells and hepatocytes, must 
have a mechanism for the release of iron to satisfy the
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needs of the body. Most of the studies covering this 
aspect of iron metabolism have been conducted on RE cells 
and will be discussed in chapter 1.4.
The release of iron from hepatocytes has been in­
vestigated in various systems of hepatocytes (Baker et al. 
1981; Baker et al, 1985; Beguin et al. 1989). It was found 
that the addition of apotransferrin and various iron 
chelators, such as citrate and desferrioxamine, to cells 
resulted in an increased rate of iron release. The release 
rate was also affected by experimental factors like incu­
bation medium and source of iron (reviewed in Thorstensen 
and Romslo, 1990). The possibility of apotransferrin 
acting as a passive extracellular iron acceptor was 
suggested by Young and Aisen (1981) when no apotransferrin 
receptors were found to be present on hepatocytes.
1.3 IRON STORAGE - FERRITIN
1.3.1 Introduction
Ferritin is a specialized iron storage protein found 
in animals, plants, fungi and bacteria (Theil, 1987). The 
protein was first crystallized from horse spleen by 
Laufberger in 1935 and he suggested that ferritin played 
a role in iron storage (Crichton and Charloteaux-Wauters,
1987). It serves a significant function in the human body 
where it sequesters toxic free iron and provides an intra­
cellular storage of iron in the soluble form (Harrison et 
al, 1977) . Ferritin is also found in very small amounts in 
serum (Jacobs, 1985; Worwood, 1990), where its deter­
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mination can be used to assess iron stores in patients. In 
the normal adult up to 1 gram of iron, depending on the 
individual's nutrition, is stored in the form of ferritin 
and haemosiderin (Bothwell et al, 1995). Ferritin is the 
soluble, mobile fraction found in the cytoplasm and 
haemosiderin is present within secondary lysosomes (Theil, 
1987; Crichton and Charloteaux-Wauters, 1987). Normally, 
about two thirds of storage iron is in ferritin mainly 
found in parenchymal cells of the liver. The greatest 
source of iron in hepatic parenchymal cells is plasma 
transferrin. However, hepatocytes also take up haemopexin 
iron, haemoglobin-haptoglobin and ferritin iron (Hershko 
et al. 1972). The remaining one third of storage iron is 
in the form of haemosiderin within the RE cells of the 
liver, spleen, bone marrow and skeletal muscle (Bothwell 
et al. 1979; Powell and Halliday, 1982) . The RE cells 
derive most of their iron by phagocytosing senescent red 
cells with removal of iron from haemoglobin. The pro­
portion of iron in haemosiderin increases as the body iron 
stores increase, an essential feature of iron overload 
disorders. The resultant haemosiderin deposits can be used 
histologically to assess the size of body iron stores. 
Iron stored in all the abovementioned sites can be 
mobilized in the face of increased body needs, and then 
transported by plasma transferrin to sites of utilization. 
The mechanisms of iron removal from ferritin or its incor­
poration into apoferritin in vivo are poorly understood. 
The mechanism whereby iron regulates ferritin synthesis
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has however received considerable interest in recent 
years. The induction of ferritin synthesis in a variety of 
tissues and cell lines by iron is now well established. 
Regulation at the level of transcription and translation 
has been described. Investigations of the molecular basis 
underlying the regulation of expression of ferritin by 
iron are currently progressing rapidly. Its significance 
in disorders of iron metabolism such as hereditary 
haemochromatosis remains to be explored.
This section describes the structural and functional 
characteristics of ferritin and the regulation of its 
biosynthesis with respect to iron.
1.3.2 Structure
Ferritin consists of a roughly spherical protein coat 
(apoferritin) enclosing a core of ferric-hydroxy-phosphate 
(Harrison et al, 1977). The protein shell (MW 45 kDa) can 
be isolated from ferritin solutions by density gradient 
centrifugation or by reduction of the ferric core and 
chelation of the ferrous ion (Chasteen and Theil, 1982; 
Crichton and Charloteaux-Wauters, 1987). The three di­
mensional structure of apoferritin has been solved by X- 
ray crystallography (Harrison, 1986) . It is composed of 24 
subunits packed in 4:3:2 symmmetry. Conservation of 
certain amino acid sequences is observed from amphibia to 
mammals (Theil, 1987). Each subunit consists of four long 
alpha helices (A to D) with a short helix E (Harrison et 
al. 1987) . The subunits interact with each other by
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hydrophilic and hydrophobic channels and salt bridges. 
Four subunits interact to form six hydrophobic channels 
and eight hydrophilic channels are formed by three sub­
units. It is thought that the hydrophilic channels are 
involved in the transport of iron in and out of the 
molecule (Theil, 1987).
The mineral core surrounded by the protein shell 
consists of hydrous ferric oxide containing some phos­
phate. Up to 4500 atoms of iron are held within each 
ferritin molecule (Mann et al. 1986) . Iron is stored in
the ferric state (Fe III) within ferritin but the ferrous 
iron (Fe II) enters ferritin via the eight hydrophilic 
channels where it is oxidized to Fe(III) (Ford et al, 
1984) . The process whereby ferritin iron is released in 
vivo is not yet clear. However, in vitro studies have 
shown that various ferric iron chelators and reducing 
agents (e.g. citrate, nitrilotriacetate, desferrioxamine, 
glutathione, ascorbic acid) are able to mediate iron 
release from ferritin (Crichton and Charloteaux-Wauters, 
1987) . Reductive mobilization of iron from ferritin by 
free radicals has also been shown (Thomas and Aust, 1986) .
Haemosiderin is a water insoluble protein-iron 
complex, believed to be formed by the partial digestion of 
ferritin aggregates by lysosomal enzymes (Munro and 
Linder, 1978; Wixom et al. 1980). The iron within haemo­
siderin is very similar to that within ferritin (Richter, 
1984) and can be mobilized during times of increased body 
needs, although it is not as accessible as ferritin 
(Bothwell et al. 1979) .
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1.3.3 Isoferritins
Multiple bands of ferritin can be observed by­
techniques such as electrophoresis in denaturing gels and 
isoelectric focusing. Arosio and co-workers (1978) pro­
posed that ferritin molecules are composed of two subunit 
types designated H (heavy, heart) and L (light, liver). 
The H-subunit (MW 21 000 daltons) consists of 178 amino 
acids and the L-subunit (MW 19 000 daltons) has 174 amino 
acids (Drysdale, 1977; Arosio et al. 1978; Worwood 1990). 
The isoelectric points of the H- and L-subunits are 4,6 
and 5,7 respectively (Bezkorovainy, 1989).
Heterogeneity of ferritin is observed in different 
tissues and is related to the presence of varying pro­
portions of the two subunits. These different ratios 
between H and L give rise to a series of isoferritins 
(Arosio et al, 1978; Bomford et al. 1981) which differ in 
immunological and electrophoretic properties. H-rich 
isoferritins are more acidic whereas L-rich isoferritins 
are more basic in nature (Powell et al, 1975a) . The 
isoferritin profile varies not only between tissues, but 
may also be altered in pathological conditions such as 
neoplasia and in cellular differentiation (Drysdale et al, 
1977; Chou et al. 1986). H-rich isoferritins predominate 
in the heart, red blood cells, monocytes and lymphocytes 
and L-rich isoferritins are more abundant in the liver, 
spleen and placenta (Powell et al, 1975a; Worwood, 1986). 
The functional differences associated with H- and L- 
subunits remain unexplained, but it has been proposed that
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the H-type ferritins turn over and take up and release 
iron faster than the L-type ferritins jji vitro (Wagstaff 
et al, 1978; Bomford et al, 1981) . In contrast, iso­
ferritins rich in L-subunits appear to retain iron more 
firmly and are found in tissues capable of storing large 
amounts of iron. There is evidence to suggest that the 
synthesis of L-rich ferritins is increased upon iron 
loading of tissues (Bomford et al. 1981; Treffrey et al. 
1984) .
cDNAs encoding the H- and L-ferritin subunits and the 
corresponding genes have been isolated and characterized 
in various species and tissues (reviewed in Theil, 1987 
and Drysdale, 1988) . In humans, the H and L chains are 
derived from multigene families (Boyd et al. 1985; Jain et 
al. 1985) . There are now about 15 H genes (Cragg et al. 
1985; Costanzo et al. 1986) and at least 5 copies of the 
human L-gene (Drysdale, 1988) . However, the H- and L-genes 
are only expressed on chromosomes 11 (llql3) and 19 
(19ql3ter) , respectively (Worwood et al. 1985) . It is
generally thought that the other genes represent non­
functional pseudogenes. It is also possible that the 
presence of ferritin genes on different chromosomes may 
protect cells against the loss of a functional gene as 
suggested by Jain and colleagues (1985) .
1.3.4 Functions
The main function of ferritin is to store iron in a 
soluble non-toxic form (Harrison et al, 1977) . Ferritin
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can be classified into three functional types according to 
Theil (1987) . These are : (i) Specialized cell ferritin 
which stores iron for use by other cells. Examples are the 
long term iron storage in hepatocytes, the recycling of 
iron to the erythron by erythrophagocytosing macrophages 
and the iron within embryonic red cells for rapid con­
sumption; (ii) intracellular housekeeping ferritin which 
maintains iron reserves for cytochromes, nitrogenase, 
ribonucleotide reductase, haemoglobin and myoglobin and 
(iii) intracellular housekeeping stress ferritin involved 
in the detoxification of excess iron during iron overload. 
For example, iron and ferritin accumulate within macro­
phages in response to inflammation. The three forms of 
ferritin are therefore found in different cell types 
serving various functions and vary according to the 
physiological state of the cells in the body. Whether 
these various ferritins are structurally different, has 
not yet been elucidated. There has however been con­
siderable interest in the transcriptional and trans­
lational control of ferritin synthesis by iron in various 
cell types. It appears that cells specialized for iron 
storage and provision of iron for use by other cells 
recruit existing ferritin messenger RNA (mRNA) for 
translation into ferritin, whereas cells that sequester 
iron to prevent toxicity or require iron for normal 
housekeeping functions exhibit changes in ferritin mRNA 
concentrations indicating control at a transcriptional 
level. This topic will be discussed in chapter 1.3.6.
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Ferritin may subserve several other functions besides 
iron storage. It has been suggested that ferritin may play 
a role in transporting iron between Kupffer cells and 
hepatocytes within the liver (Sibille et al. 1988) .
Ferritin contains small amounts of copper and zinc and may 
therefore be involved in the storage of these elements 
(Price and Joshi, 1982) . The exact function of serum 
ferritin is not known.
1.3.5 Ferritin as diagnostic tool
Small amounts of ferritin are normally present in 
plasma (Worwood, 1990). It is usually of low iron content 
(Worwood et al. 1976), consists almost exclusively of L- 
subunits and is partially glycosylated (Worwood, 1986). It 
is cleared much slower from plasma (half-life about 30 
hours) (Worwood et al, 1982) than non-glycosylated tissue 
ferritins (half-life about 10 minutes) (Cragg et al.
1983) .
The origin of serum ferritin is not clear. Its glyco- 
sylation suggests that it is synthesized by membrane-bound 
polysomes of phagocytes and secreted into the circulation 
(Bothwell et al. 1979). The main source of serum ferritin 
appears to be the RE system and the liver (Siimes and 
Dallman, 1974; Mack et al. 1981).
Normal concentrations of serum ferritin range from
about 20 to 300 /xg/liter depending on age, sex and
nutritional iron status. Values below 12 /xg/1 are
virtually diagnostic of iron deficiency whereas in
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patients with hereditary haemochromatosis values may range 
from 1000 to 10 000 ^g/1 (Bothwell et al. 1995) . Normally, 
the serum ferritin concentration is well correlated with 
the amount of storage iron in the body. It can therefore 
be used clinically to assess body iron stores (Lipschitz 
et al, 1974; Worwood, 1986) . However, it must be remem­
bered that raised serum ferritin levels may occur in 
pathological states such as infections (Baynes et al,
1986), inflammation and rheumatoid athritis (Baynes et al. 
1987a), certain neoplastic diseases (Bezwoda et al, 1985) 
and in hepatocellular disease (Prieto et al. 1975). False 
results may be observed in severe iron overload due to 
extensive tissue damage, mainly of hepatocytes, causing 
ferritin to be released (Prieto et al. 1975) and ascorbate 
deficiency which lowers serum ferritin in iron overload 
(Roeser et al, 1980) . All these limitations have to be
taken into account when interpreting serum ferritin 
levels.
1.3.6 Ferritin gene regulation and synthesis
1.3.6.1 Introduction
The amount of chelatable intracellular iron is the 
most important regulator of ferritin synthesis. It has 
been shown repeatedly in many different cell types that 
increased cellular iron increases the synthesis of 
ferritin (reviewed in Munro and Linder, 1978; Theil, 1987 
and Halliday et al. 1994).
Normally, the amount of protein synthesized by cells
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can be altered by regulation of the mRNA populations. This 
can be achieved by changing the mRNA concentrations 
effected by transcription of the corresponding genes or by 
altering the stability of the mRNA. Alternatively, the 
regulation can be modulated by varying the utilization of 
mRNA (by storage or translational efficiency) (Theil,
1987). For iron-induced ferritin biosynthesis, the regu­
lation primarily takes place at a translational level 
without changing the mRNA levels (Zahringer et al, 1976a,- 
Aziz and Munro, 1986; Rogers and Munro, 1987). Two types 
of post-transcriptional regulation are involved : (i)
recruitment of stored ferritin mRNA with no change in the 
amount of translatable ferritin mRNA (Zahringer et al, 
1976a) or hybridizable ferritin mRNA (Aziz and Munro, 
1986; Rogers and Munro, 1987) and (ii) competitive 
translation of derepressed ferritin mRNA (Shull and Theil, 
1982) . Translational control of protein synthesis is 
unusual since most cells make use of the transcriptional 
mechanism. As alluded to in chapter 1.3.4, translational 
control seems to feature more in cells specialized for 
iron storage where the stored ferritin mRNA can be rapidly 
recruited for translation into ferritin. In recent years 
sequences within ferritin mRNA involved in the iron- 
dependent regulation of ferritin biosynthesis, as well as 
cytoplasmic factors that bind to these sequences, have 
been characterized.
Control of ferritin synthesis by iron can also occur 
at the level of transcription with changes observed in the
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ferritin mRNA content (Cairo et al. 1985; White and Munro,
1988) . This mode of regulation appears more important in 
cells which require iron for housekeeping functions and in 
cells involved in the detoxification of excess iron 
(Dickey et al ■ 1987; Theil, 1987) . Here the stress of 
increased intracellular iron stimulates transcription to 
increase previously low ferritin mRNA concentrations. A 
preferential emphasis on the L-subunit has been noted in 
situations of high iron stress (White and Munro, 1988) 
which is in agreement with the finding that L-rich 
ferritins can store large amounts of iron (Bomford et al. 
1981; Treffrey et al. 1984) .
Numerous other agents are capable of inducing the 
expression of the ferritin gene. It has been shown that 
thyrotropin (Colucci-D'Amato et al. 1989; Chazenbalk et 
al. 1990), triiodothyronine (Iwasu et al, 1990), tumor 
necrosis factor (Torti et al, 1988) and insulin (Yokomori 
et al. 1991) can enhance transcription.
The site of ferritin synthesis within cells depends 
on whether ferritin is exported or kept within the cell. 
Ferritin for export (only 20%) is made on membrane-bound 
polysomes, whereas ferritin for intracellular use is 
synthesized predominantly on free ribosomes in the 
cytoplasm (Hicks et al. 1969; Lee and Richter, 1977).
1.3.6.2 Translational control
The suggestion that ferritin synthesis is regulated 
at a post-transcriptional level came from initial studies 
making use of transcription inhibitors such as Actinomycin
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D and cordycepin. The stimulatory effect of iron on 
ferritin synthesis was not suppressed by these agents 
(Drysdale and Munro, 1965; Zahringer et al. 1976a). Under 
physiological conditions, the majority of ferritin mRNA 
exists in a masked form in the cytoplasm as messenger 
ribonucleoprotein (mRNP) particles. Zahringer and co­
workers (1976b) observed that 15% of total rat liver 
poly(A)-containing RNA was present in the post-microsomal 
supernatant. This fraction was highly enriched with 
ferritin mRNA accounting for 40-50% of the total ferritin 
mRNA present in the cytoplasm. It was subsequently found 
by the same authors that upon iron administration, the 
pool of inactive ferritin mRNA from the mRNPs was released 
from storage and entered polyribosomes for active trans­
lation (Zahringer et al. 1976a) . This recruitment of 
stored message without changes in the concentration of 
ferritin mRNA has been confirmed by hybridization studies 
with cDNA probes in in vitro experiments on cultured rat 
hepatoma cells (Rogers and Munro, 1987) and in animal 
studies (Aziz and Munro, 1986). In addition, Rogers and 
Munro (1987) demonstrated that when iron was added as 
hemin, ferritin mRNA was also translocated to the polysome 
fraction. The addition of the iron chelator desferri- 
oxamine, which crosses cell membranes, inactivated the 
response to hemin. This indicates that the amount of 
chelatable iron within cells controls ferritin mRNA trans­
lation. However, Mattia and co-workers (1989) reported 
that prolonged incubation of K562 human erythroleukaemia
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cells with hemin results in increased ferritin mRNA levels 
which are not quenched by desferrioxamine, indicating the 
presence of a non-chelatable component. Alternatively, 
stabilization of the message by iron was proposed.
Competitive translation also plays a role in 
translational activation. Derepressed ferritin mRNA (by 
iron) is a strong competitor for translation initiation 
(Schaefer and Theil, 1981) . This and the fact that 
ferritin mRNA has an extremely high translational 
efficiency (Shull and Theil, 1982) allows cells specia­
lized for iron storage to respond efficiently to iron.
As previously mentioned, the ferritin subunit mRNAs 
exist within the cell as a pool of translationally in­
active mRNP. The molecular mechanisms whereby iron induces 
translational activation of ferritin synthesis is closely 
coordinated with the iron-dependent modulation of trans­
ferrin receptor mRNA. Both will therefore be discussed 
here. Excess iron results in increased translation of 
ferritin mRNA and a decrease in stability of transferrin 
receptor mRNA. These regulatory events are mediated by the 
presence of a highly conserved 28-base stem looped 
structure called the iron-responsive element (IRE) con­
tained in the 5'-untranslated region of both H and L 
ferritin mRNA (Aziz and Munro, 1987; Hentze et al. 1987). 
Five variations of these IREs are also found in the 3'- 
untranslated region of transferrin receptor mRNA (Casey et 
al. 1988). A 95 kDA cytoplasmic regulatory protein termed 
by various authors as the iron-responsive element binding
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protein (IRE-BP); iron regulatory factor (IRF); ferritin 
repressor protein (FRP) or P-90 (reviewed in Klausner et 
al, 1993), interacts with the IREs from both ferritin and 
transferrin receptor transcripts (Leibold and Munro, 1988; 
Rouault et al. 1988; Mullner et al. 1989). More recently, 
a consensus was reached to name the cytoplasmic binding 
protein (formerly IRE-BP) the iron regulatory protein 
(IRP) . The mechanism by which the IRP mediates cellular 
iron homeostasis has emerged from the observation that the 
human IRP is both structurally similar to mitochondrial 
aconitase from porcine heart and yeast (Hentze and Argos, 
1991; Rouault et al. 1991) and directly possesses aconi­
tase activity (Kaptain et al. 1991) . Aconitase is an iron- 
sulphur (Fe-S) protein that catalyzes the conversion of 
citrate to isocitrate within the Krebs cycle. Purified 
aconitase exists in an active enzymatic [4Fe-4S] state and 
in an inactive [3Fe-4S] state (Beinert, 1990) . Like 
aconitase, the IRP also possesses a dynamic Fe-S centre 
that can interconvert between two forms. The binding 
affinities of these forms for the IREs are determined by 
the iron status of the cell which appears to set the redox 
state of the IRP (Haile et al. 1989; Hentze et al. 1989b). 
The interaction of the IRP with the IRE has been proposed 
by Harford and colleagues (1994) to occur as follows : 
When iron is in excess, the IRP is in its [4Fe-4S] state 
which has high aconitase activity but low affinity for the 
IREs, resulting in increased translation of ferritin mRNA 
and decreased stability of the transferrin receptor mRNA.
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Therefore more iron is deposited into ferritin for storage 
and less iron is taken up by the cell. Conversely, when 
cellular iron becomes limiting, the IRP exists in its 
[3Fe-4S] state with negligible aconitase activity but high 
affinity for the IREs, resulting in reduced ferritin 
synthesis for iron storage and increased stability of 
transferrin receptor mRNA for more iron uptake. It is 
interesting that the genes for human cytosolic aconitase 
and the human IRP are both localized to chromosome 9 
(Rouault et al. 1990) . In fact it is now believed to be 
one and the same protein with two functions. The finding 
of IRE-like structures in mRNAs encoding 5-aminolevulinate 
synthase (Cox et al. 1991; Dandekar et al. 1991) and 
mitochondrial aconitase (Dandekar et al. 1991; Kaptain et 
al. 1991) suggests that iron may also play an important 
regulatory role in the metabolic pathways of haem bio­
synthesis and the citric acid cycle. Evidence has recently 
been provided of the existence of a second IRP termed IRP2 
which does not possess aconitase activity and differs 
partially (from the well-characterized IRP) in the regu­
lation, distribution and binding specificity (Guo et al. 
1995; Kuhn et al. 1995) .
1.3.6.3 Transcriptional control
Despite the dominant effect of iron on ferritin 
translation, there is evidence that ferritin expression is 
regulated by transcription (or mRNA stability) during 
growth, differentiation and iron overload. Developmentally 
associated changes in ferritin mRNA levels have been
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demonstrated in human promyelocytic leukaemia cells (HL- 
60) and in mouse Friend erythroleukaemia cells. A sub­
stantial increase in the ratio of H- to L-subunit mRNA was 
shown to occur during the in vitro differentiation of HL- 
60 cells to neutrophils or macrophages (Chou et al, 1986) 
as well as during erythroid differentiation of Friend 
erythroleukaemia cells (Beaumont et al. 1987) . Although 
the factors responsible for these changes during the 
differentiation process are not known, it is possible that 
variations in cellular requirements for iron may play a 
role. The influence of iron on the synthesis of house­
keeping ferritin has been studied in adult frog red cells 
(Dickey et al. 1987) . They showed that iron induces a 
change in the relative amounts of ferritin subunit mRNA in 
order to sequester any excess iron, by a process of tran­
scription or altered stability. However, in embryonic red 
cells specialized for iron storage the existing high mRNA 
levels are rapidly translated into ferritin. Further 
evidence for enhanced transcription of ferritin genes by 
iron loading has been provided by studies on HeLa cells. 
Cairo and co-workers (1985) demonstrated that upon 
incubation of HeLa cells with iron, H- and L-mRNA levels 
increased suggesting transcriptional control. However, the 
increase in ferritin mRNA levels could not account for the 
large increase in the actual ferritin level. Regulation at 
a post-transcriptional level was proposed to be involved 
as well. This coordination of both levels of regulation 
was further demonstrated by White and Munro (1988) . It was
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shown in rat liver that iron induced transcription of H 
and L genes in addition to a translational shift of both 
subunit mRNAs to polysomes; the latter mechanism allowing 
the cell to respond quickly to iron. It was also observed 
that the L-subunit was preferentially stimulated over the 
H-subunit, confirming previous findings that L-rich iso­
ferritins are more suited for iron storage (Bomford et al. 
1981) .
1.4 NORMAL RETICULOENDOTHELIAL IRON METABOLISM
1.4.1 Introduction
The reticuloendothelial system (RES) , also known as 
the mononuclear phagocyte system, consists of a diverse 
group of highly phagocytic cells. All cells of this system 
originate from precursor cells in the bone marrow giving 
rise to peripheral blood monocytes (Cline et al, 1978) . 
The blood monocytes form 4 to 8% of the total white cell 
count and have a circulating half-life of about 32 hours. 
Monocytes differentiate into histiocytes or resident 
macrophages within connective tissues of organs. These 
include hepatic Kupffer cells, perivascular macrophages of 
sinusoids of the spleen, lymph nodes and bone marrow, 
alveolar macrophages, pleural and peritoneal macrophages, 
microglial cells in the nervous system, epidermal Langer- 
hans cells and osteoclasts of bone (Cline et al, 1978) . 
Reticulum cells not only synthesize reticulin fibres in 
tissues with a supporting framework of reticular fibres, 
but also exhibit considerable phagocytic activity.
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Due to their phagocytic properties, the macrophages 
are active in the defence against injurious agents. They 
have a fundamental role in the immune response and secrete 
many biologically active products (Nathan, 1987; Auger,
1989). The RE cells, particularly of the liver, spleen and 
bone marrow, play a central role in iron metabolism. They 
are responsible for the destruction of effete and sene­
scent red blood cells and for recycling the iron released 
for synthesis of haemoglobin in the bone marrow (Lynch et 
al. 1974; Deiss, 1983). In addition, the RES serves as one 
of the major iron storage sites of the body providing an 
iron reserve which can be mobilized and protecting the 
organism against the damaging effects of iron (Finch and 
Huebers, 1982). Furthermore, the RES plays a role in the 
regulation of iron absorption via the amount of iron 
stored (Bezwoda et al, 1979; Rosenmund et al, 1980). The 
precise regulatory mechanism by which this process is 
effected is unknown.
In the sections that follow, iron entry into RE 
cells, intracellular events and iron release by RE cells 
will be discussed.
1.4.2 Iron uptake bv RE cells
The RES derives most of its iron from haemoglobin of 
broken down red cells. Of the 30 mg of iron exchanged 
daily with the RES, two thirds are derived from erythro­
cytes and the remainder from ineffective erythropoiesis 
(Cook et al. 1970) . Phagocytosis of senescent or damaged
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red cells occurs predominantly in the RE cells of the 
spleen, liver and bone marrow (Deiss, 1983) . To study iron 
uptake experimentally, red cells labelled with radioiron 
can be damaged by physical, chemical or immunological 
means and then infused. The splenic cords of the red pulp 
appear to be the main site of phagocytosis of effete red 
blood cells (Rosse, 1987). It is still not clear whether 
the destruction is purely a mechanical process or whether 
immunological recognition may play a role. Phagocytosis of 
red cells has also been observed in the liver and bone 
marrow under different conditions (Hughes Jones and 
Cheney, 1961; Frank et al. 1972). Deiss and Cartwright 
(1970) documented that RE cells may directly receive small 
amounts of ferritin from within red blood cells. 
Haemoglobin bound to haptoglobin or hemopexin, free 
haemoglobin and hemin are not removed by RE cells, but by 
hepatocytes and kidney cells (Hershko et al. 1972).
A small amount of iron may also be delivered to RE 
cells by the iron transport protein, transferrin. Several 
studies have reported transferrin-bound iron uptake by 
cultured macrophages (Summers and Jacobs, 1976; Wyllie, 
1977; Sizemore and Bassett, 1984; Baynes et al, 1987b). 
The number of transferrin receptors on monocyte- 
macrophages varies substantially in different situations. 
Transferrin receptor expression is absent or decreased on 
human monocytes and on resident (quiescent) and activated 
(fully cytolytic) macrophages. However, the expression is 
increased on responsive macrophages (cells that become
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cytolytic in response to an appropriate signal) and on 
cultured macrophages (Andreesen et al, 1983 & 1984; Adams 
and Hamilton, 1984; Hirata et al. 1986; Testa et al. 
1989). With regard to iron and transferrin receptor 
expression in RE cells, an interesting study by Testa and 
co-workers (1989) revealed that iron salts induce an 
upregulation of both transferrin receptor RNA and trans­
ferrin receptors in human cultured maturing macrophages. 
This was supported by a recent study demonstrating that 
iron-transferrin enhances transferrin receptor expression 
in nonactivated cultured monocytes (Byrd and Horwitz, 
1993). These findings are in sharp contrast to the effect 
observed in most other cells types: excess iron leading to 
a downregulation of transferrin receptor expression 
(discussed in chapters 1.2.5.3 and 1.3.6.2). It has been 
suggested that the increase in transferrin receptors 
allows macrophages to store large amounts of iron.
In most studies it has only been speculated that 
transferrin iron is taken up by cultured macrophages by a 
process of receptor mediated endocytosis. Baynes and co­
workers (1987b) studied the effect of various metabolic 
inhibitors on receptor mediated endocytosis and concluded 
that an endocytic pathway similar to that in erythroid 
precursors may be present in human cultured blood mono­
cytes. The biological significance of these observations 
and the role of the transferrin receptor is not clear 
since RE cells derive most of their iron from degraded 
haemoglobin.
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The iron-binding glycoprotein, lactoferrin has been 
suggested to be involved in the delivery of iron to RE 
cells. Uptake of iron from lactoferrin has been demon­
strated in mouse peritoneal macrophages (van Snick et al. 
1977) and in human monocytes (Birgens et al, 1988) . 
Lactoferrin receptors have also been identified on 
monocytes (Birgens et al. 1983).
1.4.3 In t r a c e l lu la r  iron  piPt-.ahnl i am
Erythrocytes that have been engulfed by phagocytosis 
are degraded by lysosomal enzymes which are released by 
fusion of the phagocytic vesicles with the lysosomes 
(Lynch et al. 1974) . After globin is split from met- 
haemoglobin, iron is released from the haem component by 
the action of microsomal haem oxygenase (Tenhunen et al, 
1972) with the formation of carbon monoxide and bili- 
verdin. Haem oxygenase activity is low in monocytes but is 
induced by uptake of haemoglobin (Schacter, 1988) .
The iron from haemoglobin catabolism may either 
return to the plasma or become stored as ferritin or 
haemosiderin. Although the major portion of this iron is 
released to transferrin (Noyes et al. 1960) , many factors 
such as body iron stores, erythropoiesis, inflammation and 
ascorbic acid deficiency may affect the balance between 
the two pathways. The passage of iron through RE cells has 
been characterized in dogs (Fillet et al, 1974) and in 
humans (Fillet et al. 1989) using radiolabelled heat 
damaged red cells. From these studies it appears that iron
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released from haem passes through a labile intracellular 
iron pool from which it either returns to the plasma or 
exchanges with the slow storage pool. Iron release from RE 
cells will be discussed in chapter 1.4.4.
The slow storage pool represents ferritin and haemo- 
siderin. As mentioned previously (chapter 1.3.4), macro­
phages may contain three types of ferritin namely 
specialized cell ferritin for use by other cells, house­
keeping ferritin for intracellular purposes and house­
keeping stress ferritin for situations of iron overload. 
Monocytes contain ferritin with a relatively high H- 
subunit content (Powell et al. 1975a; Jones et al. 1983). 
However, their in vitro maturation to macrophages is 
associated with an increase in L-rich isoferritins 
characteristic of iron storage organs such as liver and 
spleen (Worrall and Worwood, 1991). Accumulation of L-rich 
isoferritins has also been observed in macrophages after 
erythrophagocytosis (Harrison, 1986; Raha-Chowdhury et al, 
1993) or by incubation with iron salts (Worrall and 
Worwood, 1991). It is not known whether this increase was 
caused by transcriptional or translational mechanisms. A 
more detailed study conducted by Testa and co-workers 
(1989) showed that expression of H and L ferritin chains 
at RNA and protein levels was considerably higher in 
cultured macrophages than in fresh monocytes. This 
indicates either enhanced transcription of the ferritin 
genes or regulation at a translational level. Upon the 
addition of iron as ferric ammonium citrate, an increase
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in both H- and L-ferritin was associated with only a 
moderate rise in the corresponding RNA components, 
suggesting regulation at a translational level. Byrd and 
Horwitz (1993) similarly showed that incubation of 
cultured macrophages with transferrin-bound iron results 
in an up-regulation of the intracellular ferritin content. 
It appears that iron regulation of ferritin synthesis in 
monocyte-macrophages may occur at either transcriptional 
or translational levels or both depending on the degree of 
differentiation or the cell's iron status or its particu­
lar function at any one time.
1.4.4 Iron release by RE cells
The RES serves as the major source of iron for the 
plasma iron pool (Morgan, 1981). Transferrin is respon­
sible for transporting this iron to the erythron for 
haemoglobin synthesis. RE cells release iron in proportion 
to body needs. In iron deficiency, the iron from haemo­
globin catabolism returns to the plasma with very little 
being stored (Bentley et al, 1979) . The level of erythro- 
poiesis also affects RE iron release. For example stored 
iron is rapidly mobilized in situations of acute bleeding. 
However, in two clinical situations this pattern does not 
apply. In the anaemia of chronic disorders, low plasma 
iron and transferrin saturation are coupled with greater 
than normal levels of storage iron in RE cells and mucosal 
cells (Roeser et al, 1980), suggesting a failure of mono­
nuclear cells to release iron despite a significant
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concentration gradient. In contrast, in idiopathic haemo- 
chromatosis plasma transferrin and parenchymal cells are 
markedly iron overloaded with very little iron in the RE 
cells (Brink et al, 1976), possibly indicating release by 
these cells against a concentration gradient. From these 
observations, the release of iron from RE cells may be 
effected by an active process. The possibility that apo- 
transferrin receptors within the membrane of RE cells may 
play a role in iron release has been investigated. A study 
by Baynes and co-workers (1987b) on cultured human blood 
monocytes provided no evidence of apotransferrin receptors 
indicating that iron release from the RE cells does not 
occur via this pathway.
RE iron kinetics in dogs showed that radioiron is 
released from RE cells in a biphasic manner after the 
infusion of labelled heat damaged red cells. It was shown 
that there was an initial early release phase (from haem 
catabolism) with a half-time of 34 minutes and a late 
release phase (release from RE stores) with a half-time of 
7 days (Fillet et al, 1974). A subsequent study investi­
gating RE iron kinetics is vivo in humans was presented by 
Fillet and co-workers, 1989. It was shown that after a lag 
period of about 40 minutes, two thirds of the freed 
radioiron from haemoglobin were returned to the plasma 
with a half-time of 33 minutes and one-third was incor­
porated into RE stores and released at a slower rate 
(half-time of 6 days).
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Iron may be released in the form of ferritin by RE 
cells. Brock and co-workers (1984) showed that a small 
amount of ferritin was released from mouse peritoneal 
macrophages after their incubation with radiolabelled 
transferrin-antitransferrin immune complexes. Similarly, 
isoferritins were detected in the iron-containing medium 
of peripheral blood mononuclear cells (Worwood et al,
1984). Using a haemolytic plaque forming assay, de Sousa 
and colleagues (1982) provided further evidence of 
ferritin secretion from mononuclear phagocytes. A recent 
in vitro study investigating the molecular form in which 
iron is released from human monocytes and monocyte derived 
macrophages, showed that 25 to 30% of released iron 
appeared to be present as low molecular weight iron 
compounds in the cell culture supernatants. Ferritin-bound 
iron could not be detected (Moura et al, 1995) .
The release of iron from RE cells also appears to be 
dependent upon the availability of caeruloplasmin. Caeru­
loplasmin acts as a ferroxidase catalyzing the conversion 
of ferrous iron to the ferric state, the latter being 
normally bound to transferrin. Caeruloplasmin may there­
fore facilitate the mobilization of iron from RE cells by 
this mechanism (Frieden and Osaki, 1974).
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1.5 HLA-LINKED HAEMOCHROMATOSIS
1.5.1 Introduction
The term "haemochromatosis" was first introduced by 
von Recklinghausen in 1889. The pathological term can be 
defined as the presence of excessive amounts of iron in 
parenchymal cells leading eventually to cellular damage 
and functional impairment of organs, while the term 
"haemosiderosis" is reserved for tissue iron overload 
without evidence of cellular damage (Bothwell et al, 
1995). The causes of haemochromatosis are multiple. The 
most common and the most severe iron overload is found in 
the genetic disorder; it has been designated idiopathic, 
primary, genetic or hereditary haemochromatosis. HLA- 
linked haemochromatosis may be the most appropriate term 
since HLA association defines the disease. The other 
causes of haemochromatosis can collectively be called 
secondary haemochromatosis. These include causes secondary 
to anaemia and ineffective erythropoiesis (e.g. thalas- 
saemia and sideroblastic anaemia, usually compounded by 
multiple transfusions), to liver disease (e.g. alcoholic 
cirrhosis and following portocaval anastomosis) and to 
high oral iron intake in African iron overload (Powell et 
al. 1980) .
This dissertation is concerned with HLA-linked 
haemochromatosis. In the sections that follow the 
genetics, pathogenesis, clinical features and diagnosis of 
the disease will be briefly discussed. The sites of 
possible abnormalities of hereditary haemochromatosis are 
also dealt with here.
39
1.5.2 Genetics
HLA-linked haemochromatosis occurs as a result of an 
inborn error of metabolism in which dietary iron absorp­
tion is inappropriately increased in relation to body iron 
stores (Bothwell et al, 1995). The disease is inherited as 
an autosomal recessive trait. Sheldon (1935) first 
suggested that this disease was inherited, but it was only 
found much later that the phenotypic expression of haemo­
chromatosis was linked with HLA haplotypes (Simon et al. 
1975 & 1977) . The HLA antigen A3 occurs in about 70% of 
individuals with this condition, while only 28% of the 
general European population are HLA-A3 (Simon et al, 
1980) . In addition, HLA-B7 and HLA-B14 (Walters et al, 
1975a; Simon et al, 1976) and HLA-A2 and HLA-All (Summers 
et al. 1990) have also been associated to a lesser extent 
with hereditary haemochromatosis.
The gene for hereditary haemochromatosis has not yet 
been identified but is known to lie close to the HLA-A 
locus on the short arm of chromosome 6 (6p) (Edwards et 
al. 1980a; Powell et al, 1994) . Recent studies making use 
of recombination mapping have confirmed that the gene is 
in fact very closely linked to HLA-A2 (Gasparini et al, 
1993; Jazwinska et al, 1993). cDNAs which may encode the 
haemochromatosis gene have been identified (El Kahloun et 
al. 1993). The gene frequency for hereditary haemo­
chromatosis is about 0,05 in most Caucasian populations 
corresponding to a heterozygote frequency of 10%. Approxi­
mately 3 in every 1000 individuals are homozygous for
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haemochromatosis (Simon et al, 1977; Cartwright et al. 
1979) . Full clinical expression of the disease is most 
commonly seen in individuals homozygous for the gene. 
Heterozygotes have less pronounced metabolic aberrations 
and often only have mild biochemical abnormalities (Simon 
et al, 1980).
1.5.3 Pathogenesis and clinical manifestations
Normal total body iron is about 4 g (Bothwell et al. 
1979) . In patients with HLA-linked haemochromatosis the 
total body iron content is 15 to 40 g. However, the iron 
stores are increased between 20 to 50 times the normal as 
the surplus iron is held within the storage compounds 
(Bothwell et al, 1979). The iron stores accumulate over a 
number of years and with an excessive absorption amounting 
to 4 mg per day or more, the disease usually becomes 
clinically manifest at 40-60 years of age. Males have a 
10-fold greater disease incidence than females. This can 
be attributed, in part, to iron losses afforded by 
menstruation, pregnancy and lactation and to a low dietary 
intake in females (Bothwell et al. 1995) . Since the pheno­
typic expression of the gene is likely to depend on the 
amount of available iron in the diet, a high dietary iron 
intake and excessive alcohol consumption may accelerate 
the accumulation of iron (Bothwell et al, 1995).
The excess iron is deposited in parenchymal cells 
mainly in the form of haemosiderin. The organs and tissues 
most commonly affected are the liver, pancreas, heart,
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endocrine organs, skin and joint linings. An integral part 
of the disease is the insignificant involvement of the RES 
and the intestinal mucosal cells (Valberg et al. 1975; 
Brink et al. 1976; McClaren, 1989) . This contrasts with 
transfusion iron overload where the iron is deposited 
largely in the mononuclear phagocyte system.
The principal manifestations of hereditary haemo- 
chromatosis include cirrhosis, cardiomyopathy, diabetes 
mellitus, hypogonadism, skin pigmentation and athritis 
(Bothwell et al, 1995) . It has been proposed that iron 
causes tissue injury by the formation of free radicals 
such as hydroxyl radicals, which then cause lipid 
peroxidation of subcellular organelles (Bacon and Britton, 
1989). A recent study has suggested that increased plasma 
levels of thiobarbituric acid-reactants found in patients 
with hereditary haemochromatosis could be the result of 
increased peroxidation (Young et al ■ 1994) . The disruption 
of iron-laden lysosomes leading to the release of hydro­
lytic enzymes (Selden et al, 1980), damage to DNA, reduced 
cellular levels of ATP and impaired cellular calcium 
homeostasis may all contribute to cellular injury in iron 
overload (reviewed in Britton et al, 1994).
The primary treatment of HLA-linked haemochromatosis 
is to remove the excess iron by repeated phlebotomy 
(Bothwell et al. 1979) . Initially, weekly or even twice 
weekly venesections of 500 to 600 ml of blood for about 1­
3 years is required. Thereafter, maintenance venesection 
every 3 to 4 months is required to counteract further 
accumulation of iron (Bothwell et al. 1995) .
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1.5.4 Diagnostic methods
Once hereditary haemochromatosis is suspected, the 
body iron status can be assessed by various biochemical 
tests. The combined measurements of the (1) serum iron 
(SI) concentration (2) percent transferrin saturation and 
(3) serum ferritin (SF) levels provide a reliable 
screening test for the disease. The SI level and percent 
saturation of transferrin are elevated early in the course 
of the disease, even before the body iron content is 
increased (Bassett et al. 1984). The SI concentration is
usually above 200 ng/dL (normal 60 to 150 pig/dL) in the 
later stages. The SI levels may however be normal in young 
male patients and in some females with the disease 
(Edwards et al, 1980b) and may be increased with iron
medication (Bothwell et al, 1995) . The percentage satu­
ration of transferrin (serum iron divided by total iron 
binding capacity) is usually a reliable indicator of 
hereditary haemochromatosis. A saturation above 62% has 
been found in 92% of individuals homozygous for the 
disease (Dadone et al, 1982) . A transferrin saturation
greater than 70% is virtually diagnostic of iron overload. 
The transferrin saturation may however be decreased by the 
concomitant presence of infection or a hepatoma (Bothwell 
et al, 1995) . To eliminate false positives and false
negatives the saturation must be measured on more than one 
occasion, preferably fasting.
The SF level is proportional to body iron stores and 
is therefore a useful indicator of the iron storage
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compartment (Lipschitz et al, 1974; Worwood, 1986) . SF may­
be elevated out of proportion in certain clinical 
conditions such as infection, malignancy and hepatic 
necrosis (discussed in chapter 1.3.5) which makes it a 
poor indicator of iron overload on its own.
The definitive test of HLA-linked haemochromatosis is 
liver biopsy. It permits histological staining for iron, 
measurement of iron concentration and assessment of the 
extent of liver damage. The hepatic iron index (liver iron 
concentration divided by age) with values greater than 1.9 
is useful in the diagnosis of the disease (Bassett et al, 
1986) . Newer noninvasive tests for measuring body iron 
stores are being developed and include computed tomo­
graphy, magnetic resonance imaging and magnetic suscepti­
bility measurement (Brittenham, 1988), but these are not 
suitable for routine use.
Screening of siblings of known homozygotes by HLA 
typing together with studies of their iron status is 
important in the early diagnosis of hereditary haemo­
chromatosis (Haddy et al. 1988) .
1.5.5 Nature of the metabolic defect
1.5.5.1 Introduction
The underlying metabolic defect which results in iron 
overload in HLA-linked haemochromatosis remains to be 
elucidated. Numerous proposals have been made as to the 
possible sites at which an abnormality may be found. These 
sites include the intestine, liver and RES. An abnormality
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in transferrin or its receptor and ferritin has also been 
suggested. A complete discussion of each site is beyond 
the scope of this dissertation and only the most important 
aspects are highlighted. More emphasis is placed on RE 
iron metabolism in haemochromatosis.
The Intestine. The reason for the increased iron 
absorption inappropriate to body needs remains unknown. An 
abnormality in the mucosal epithelium of the upper small 
intestine has been suggested by numerous investigators. 
From is vitro studies Cox and Peters (1978) proposed an 
increased avidity for iron by mucosal cells. Evidence to 
suggest that the mucosal storage pool may be impaired has 
been provided by studies showing that the ferritin content 
is reduced in these cells (Crosby, 1963; Fracanzani et al, 
1989). Other studies have suggested that the mucosal iron 
uptake and transfer of mucosal iron to the circulation are 
increased in haemochromatosis (Powell et al, 1970; Marx, 
1979). Recent work by Pietrangelo and co-workers (1992 & 
1993) demonstrated an increase in the steady state mRNA 
for the transferrin receptor in duodenal mucosa, whereas 
for ferritin both mRNA and protein levels were reduced. It 
was suggested that a reduced iron pool may have led to 
this effect. Furthermore, it has been shown that the 
coordinate regulation by iron of ferritin synthesis and 
transferrin receptor expression (IRP-IRE mechanism) 
appears to be intact in haemochromatosis (Pietrangelo 
1993) . Of importance here, is the in vivo investigation of 
mucosal iron transport kinetics by McClaren and co-workers
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(1991) in which it was demonstrated that the increased 
iron absorption is mediated mainly by an increase in the 
rate constant for transfer of iron from the mucosa to 
plasma rather than an abnormality in the regulation of 
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The Liver. From studies conducted by Pollycove et al 
(1971) and Batey et al (1978) on treated patients with 
haemochromatosis, it has been suggested that the hepatic 
parenchymal cells have an increased affinity for iron. 
This can not be so since iron stores are easily mobilized 
following phlebotomy of haemochromatosis patients 
(Bothwell et al, 1979) . The hepatocyte iron uptake by
various pathways has been identified and discussed in 
chapter 1.2.6.1. A study by Sciot and co-workers (1987)
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using immunohistochemical staining of liver biopsies 
showed that in untreated haemochromatotic patients the 
transferrin receptor expression was absent on hepatocytes. 
These findings are in keeping with the known effect of 
iron on transferrin receptor expression [see chapter 
1.2.5.3] . In the absence of transferrin receptors the 
liver however continues to accumulate more iron. Other 
pathways for iron uptake may become operative. The uptake 
of non-transferrin-bound iron is vitally important in 
haemochromatosis where up to 3 0% of serum iron is not 
bound to transferrin (Batey et al, 1980). Liver ferritin 
does not appear to be defective in hereditary haemo­
chromatosis. Although an abnormal pattern of liver 
isoferritins is observed in untreated patients (Powell et 
al, 1974), the pattern is also seen in other types of iron 
storage disease (Powell et al. 1975b) . Furthermore, with 
depletion of iron the abnormal pattern returns to normal.
The RES. Possible defects in iron metabolism in RE 
cells of patients with haemochromatosis are discussed 
below.
1.5.5.2 RE iron metabolism
In hereditary haemochromatosis iron deposition in RE 
cells is inappropriately low compared to the size of 
parenchymal iron stores (Ross et al, 1975; Valberg et al, 
1975; Brink et al. 1976). The transferrin saturation is 
increased even before the body has accumulated significant 
amounts of iron (Bothwell et al. 1995) . This suggests a 
defect in RE iron uptake or storage in the disease. Three
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aspects which may explain the abnormal behaviour of these 
cells have been extensively investigated and include iron 
uptake, iron storage and iron release.
Iron Uptake. Normally, iron absorption is inversely 
related to RE iron stores (Charlton et al. 1977; Bezwoda 
et al, 1979; Rosenmund et al. 1980). An impaired RE iron 
uptake may therefore result in an abnormally increased 
level of iron absorption. Although RE cells derive most of 
their iron from effete red blood cells, a small amount can 
be obtained from circulating transferrin [discussed in 
chapter 1.4.2) . Several in vitro studies have investigated 
the latter pathway. Studies on peripheral blood monocytes 
have shown no difference in transferrin iron uptake 
between treated haemochromatotic patients and normal 
control subjects (Jacobs and Summers, 1981; Sizemore and 
Bassett, 1984) . The work by McClaren and co-workers (1979) 
does not support this observation. They showed that the 
mean iron uptake from 100% saturated transferrin by 
monocytes from treated haemochromatotic patients was 
significantly lower than that demonstrated in normal 
monocytes (uptake of 3,16 ± 2,79 pmol/106 cells in treated 
patients compared with 12,32 ± 7,6 pmol/106 cells in 
normals; p < 0,02). It was concluded that a defect in iron 
uptake may account for the paucity of iron in RE cells. 
Interestingly, Sizemore and Bassett (1984) demonstrated a 
significant reduction of transferrin iron uptake by 
monocytes from iron-loaded haemochromatotic patients 
(uptake of 0,96 ± 0,30 fg/cell for iron-loaded patients
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compared with 1,99 ± 0,87 fg/cell for normal subjects; 
p < 0,01) . The authors suggested that the effect observed 
in monocytes from iron-loaded patients was merely a homeo­
static mechanism of cellular iron metabolism.
The possibility of a defect in transferrin receptors 
has been raised. An extensive study on cultured human 
blood monocytes was conducted by Baynes and colleagues 
(1989) . Scatchard analysis of binding curves failed to 
demonstrate any significant difference in the number or 
binding affinities of transferrin receptors on cultured 
macrophages from haemochromatotic patients and normal 
subjects. The results are in agreement with the findings 
of Ward and co-workers (1984a) . In this study no diffe­
rences in the properties of transferrin receptors on 
cultured fibroblasts or lymphocytes between patients with 
haemochromatosis and normal subjects were found. In 
contrast to the above, transferrin receptor expression has 
been found to be increased in peripheral blood monocytes 
from patients with haemochromatosis (Bjorn-Rasmussen et 
al, 1985) . The biological significance of enhanced
receptor expression is unclear, since RE cells in 
haemochromatosis accumulate very little iron.
Of interest is a report by Testa and co-workers 
(1989) that iron up-regulates transferrin receptor mRNA 
and transferrin receptors in normal cultured macrophages, 
suggesting an increased ability of these cells to take up 
more iron for storage. It is not known whether haemo­
chromatotic mononuclear phagocytes are subject to the same 
mode of regulation.
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It is important to remember that the uptake of 
transferrin iron by RE cells ia vivo is relatively in­
significant compared to the amount of iron obtained from 
erythro-phagocytosis. Therefore, studies that over­
emphasize the former pathway as playing a major role in 
the possible pathogenesis of hereditary haemochromatosis 
must be viewed with caution.
Iron Storage. An inability of RE cells to synthesize 
ferritin and store iron might also explain the scarcity of 
RE iron stores, the increased absorption and excess depo­
sition of iron in parenchymal cells. Although Green and 
colleagues (1978) reported that monocyte ferritin content 
is disproportionately low in haemochromatosis, most 
studies do not support the hypothesis that ferritin 
synthesis is abnormal in RE cells. In a study comparing 7 
treated haemochromatotic patients and 24 normal subjects, 
no difference between the two groups in either ferritin 
synthesis or the amount of iron incorporated into ferritin 
was observed (Jacobs and Summers, 1981) . This was con­
firmed by a study demonstrating that monocyte ferritin 
synthesis, after induction with ferric ammonium citrate or 
iron dextran, did not differ significantly between treated 
patients and control subjects (Bassett et al, 1982) . A 
study conducted by Worrall and Worwood (1991) on the 
immunological properties of ferritin showed that monocyte 
H- and L-type ferritins increased to the same extent 
(after iron induction) in patients with haemochromatosis 
and normal subjects. With maturation in culture to macro­
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phages, the ratio of L- to H-type ferritin subunits 
increased similarly in both study groups. From the above 
observations it appears unlikely for there to be an 
abnormality in ferritin synthesis in haemochromatotic RE 
cells.
However, in an interesting report by Gordeuk and co­
workers (1992) cultured monocytes from haemochromatosis 
patients released decreased amounts of tumor necrosis 
factor-a (TNF-a) compared with normal cells. TNF-a induces 
the expression of ferritin-heavy chain mRNA (Torti et al,
1988) and reduces the amount of iron released by peri­
toneal macrophages (Alvarez-Hernandez et al, 1989) . The 
author therefore suggested that a reduced amount of TNF-a 
from haemochromatotic monocytes may result in inhibition 
of ferritin synthesis and enhanced release of iron from 
these cells. It should be noted that the gene for TNF-a is 
located close to the HLA locus on chromosome 6 (Spies et 
al, 1986) , the same chromosome on which the gene for 
hereditary haemochromatosis is found.
It is well known that iron greatly influences 
translation of ferritin mRNA effected by binding of the 
IRP to IREs [discussed in chapter 1.3.6.2]. It has been 
postulated that a mutation in the IRP may account for the 
abnormal iron metabolism in haemochromatotic mononuclear 
phagocytes (Kuhn, 1991). It does not appear likely since 
the IRP is coded on chromosome 9 (Hentze et al, 1989a) 
rather than chromosome 6.
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Iron Release. The paucity of iron in RE cells may 
relate to enhanced release of iron. Very little is known 
about this aspect in haemochromatotic cells. Flanagan and 
co-workers (1989) documented an increase in the release of 
ferritin from monocytes derived from untreated and treated 
haemochromatotic patients. The iron content of the 
ferritin was however not determined. The observations of 
this study await confirmation.
Iron release from normal and haemochromatotic macro­
phages was found not to increased when the cells were 
incubated in the presence of an extracellular-acting 
hydrophillic chelator (Baynes et al, 1989) . Furthermore, 
Baynes and co-workers (1989) showed that apotransferrin 
does not appear to be essential for iron release.
The first jja vivo study in humans to investigate iron 
kinetics in the RES using a physiologic RE tag was 
conducted by Fillet and co-workers (1989). Early RE 
radioiron release (from haem catabolism) was substantially 
increased in patients with haemochromatosis compared with 
subjects with similar iron stores. A defect in RE cells to 
retain iron freed from haemoglobin could result in an 
increased delivery of iron to the plasma. This would lead 
to high serum iron concentrations and increased loading of 
binding sites on transferrin. McClaren and co-workers 
(1991) in their study on intestinal iron absorption and 
mucosal iron kinetics in haemochromatosis, observed that 
the increased absorption can be attributed to an increased 
transfer rate (release) of mucosal iron in this disorder.
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Since both mucosal cells and RE cells do not store iron
appropriately, it was suggested that a common pathway of 
enhanced iron release may be operative in these tissues.
In conclusion, it appears that the only unifying 
hypothesis to account for the defect in HLA-linked 
haemochromatosis is that the RE cells are unable to hold 
iron leading to excess iron in the circulation, an 
increased transferrin saturation and an increase in non­
transferrin-bound iron. How the release of iron is 
accomplished and in what form the iron is released is not 
known. Nevertheless, it suggests that this may be a 
disorder of iron release at a primary level and that the 
iron overload leading to toxicity is merely a secondary 
event. Furthermore, it appears that in order to clarify 
the basic lesion of haemochromatosis the abnormal gene or 
the abnormal gene product has to be identified.
1.6 AIMS OF THE PRESENT STUDY
The investigation of patients with HLA-linked 
haemochromatosis was of particular interest in this study 
because the reason why RE cells exhibit lesser degrees of 
iron overload compared to parenchymal cells, is not known. 
Macrophages are widely regarded as cells of the RES. 
Peripheral blood monocytes are precursors of macrophages 
and are easy to isolate and culture for experimental 
investigation. The attention of this study has therefore 
been focussed on certain aspects of cellular iron 
metabolism involving the in vitro culture of macrophages
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for 8 days from patients with hereditary haemo- 
chromatosis.
A prerequisite for performing experiments on the cell 
population chosen, was to ensure that macrophages from 
normal and haemochromatotic subjects remained viable after 
8 days in culture. To this end, a study was conducted to 
determine viability of these cells by trypan blue dye 
exclusion and to determine metabolic integrity (as a 
measure of viability) of uridine and leucine incorporation 
into RNA and protein, respectively.
It has been postulated that an impaired iron uptake 
by mononuclear phagocytes may be responsible for the 
uneven distribution of iron noted in HLA-linked haemo- 
chromatosis. The available information on transferrin iron 
uptake by monocytes and in particular cultured macrophages 
in this disorder is sparse. A study was aimed at comparing 
the handling of transferrin and transferrin iron by 8 day 
cultured macrophages from normal subjects and patients 
with hereditary haemochromatosis.
An abnormality in the regulation of ferritin syn­
thesis has also been proposed as a possible mechanism 
accounting for the increased iron output by RE cells in 
hereditary haemochromatosis. To gain an insight into the 
expression of iron-regulated genes (ferritin H and L 
subunits) a study was aimed at directly measuring the 
level of early gene products (i.e., H- and L-ferritin 
mRNAs) in response to iron in 8 day cultured macro­
phages. Prior to the investigation of ferritin mRNA,
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preliminary experimental methods were aimed at comparing 
various RNA isolation techniques from cultured macro­
phages. Although the central theme of this dissertation 
revolves around some aspects of cellular iron metabolism 
in haemochromatotic macrophages, the refinement and 
application of laboratory procedures were regarded as the 
cornerstone of this study.
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SECTION 2
CELL BIOLOGY OF HAEMOCHROMATOTIC MACROPHAGES : 
GROWTH CHARACTERISTICS, VIABILITY STUDIES AND 
METABOLISM.
IRON
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SECTION 2
CHAPTER 2
BASIC CELL BIOLOGY METHODS
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2.1 INTRODUCTION
Various experiments including cell viability, 
transferrin iron uptake and ferritin mRNA studies 
performed on cultured mature macrophages of patients with 
hereditary haemochromatosis and normal subjects are 
presented in this dissertation. Chapter 2 describes basic 
methods for the isolation of peripheral blood monocytes, 
their culture and growth characteristics. Viability 
studies as assessed by trypan blue exclusion, uridine and 
leucine uptake by cultured macrophages are also presented 
here. Chapter 3 deals with transferrin-iron-macrophage 
interactions. For convenience of presentation the deter­
mination of ferritin mRNA expresssion in cultured macro­
phages is discussed in section 3 (chapters 4 and 5) as 
this is mainly concerned with molecular biological 
techniques.
2.1.1 Subjects studied
The studies for this dissertation were approved by 
the University of the Witwatersrand Committee for Research 
on Human Subjects (protocol no. 15/8/89). Portions of 
blood samples taken during phlebotomy therapy of patients 
with haemochromatosis admitted to the Johannesburg 
Hospital, were used for the purpose of this study. Normal 
healthy volunteers from the Department of Medicine served 
as controls. Informed consent was obtained prior to the 
investigations. In total 8 haemochromatotic patients and 
8 normal subjects were studied.
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2.1.1.1 Diagnosis of haemochromatosis
The diagnosis of hereditary haemochromatosis was 
based on an elevated serum ferritin ( > 250 /ig/1) , serum 
iron ( > 150 /xg/dl) and transferrin saturation ( > 60%) , 
on an increased hepatic non-haem iron index ( >2) and on 
compatible family studies (Ref. values: Powell et al,
1994; Bothwell et al, 1995). In addition, patients
exhibited a wide variety of physical features charac­
teristic of the disease. No patient had received blood 
transfusions or iron therapy and there was no evidence of 
excessive alcohol intake.
2.l.l. 2 Laboratory assessment of subjects
Blood specimens drawn from each subject were used for 
the following investigations:
(i) Full blood count and differential count on an HI 
electronic counter (Technicon, Terrytown, New 
York)
(ii) Serum iron concentration and total iron binding 
capacity (International Committee for Standardi­
sation in Haematology, 1978 a&b)
(iii) Serum ferritin concentration measured by an 
enzyme linked immunoadsorbent assay (Conradie 
and Mbhele, 1980)
2.2 CELL CULTURE TECHNIQUES
2.2.1 Isolation of blood mononuclear cells
Mononuclear cells were isolated from whole blood by 
density gradient centrifugation on Ficoll-hypaque using a
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modification of the technique described by Boyum (1968). 
In this technique, blood is spun on a fluid of high 
density (Ficoll-hypaque) resulting in the separation of 
blood cells into an upper fraction consisting of mono­
nuclear cells and platelets at the interface and a 
sedimented fraction containing granulocytes and erythro­
cytes .
Blood removed by venesection from 8 normal volunteers 
and 8 patients with haemochromatosis was collected in 500 
ml vaculiter containers with 70 ml citrate as anti­
coagulant. Serum samples were prepared by allowing freshly 
drawn blood to clot in 10 ml vac-u-test tubes. The 
citrated blood was mixed with an equal volume of sterile 
0,9% saline as recommended by Boyum (1968) . 33 ml of 
diluted blood was carefully layered onto 17 ml Ficoll- 
hypaque in 50 ml sterile screwcap tubes (Nunc). Layering 
of blood with minimal disturbance at the interface was 
achieved by tilting the tube from the horizontal and 
allowing filling to proceed slowly. The use of a pipette, 
as described by Boyum (1968), a syringe or a tap attached 
to a sterile tube proved to be time-consuming and 
laborious. The tubes were then centrifuged at 1400 rpm for 
30 minutes at 4°C. The upper plasma layer was carefully 
removed and the mononuclear cell fraction was collected 
from the interface using a Pasteur pipette. The cells were 
washed 3 times by centrifugation at 1000 rpm for 20 
minutes at 4°C using cold sterile RPMI medium (Highveld 
Biological, Johannesburg, South Africa) for removal of
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platelets and Ficoll-hypaque. The resulting mononuclear 
cell pellet was resuspended in an appropriate volume of 
Basal Medium Eagle serum saver (BMESS) (Highveld Bio­
logical, Johannesburg, South Africa) with 10% autologous 
serum. After adequate mixing, 10 fj. 1 of the cell suspension 
was diluted in 90 ptl white cell staining fluid (0.025% 
methyl green, 1% glacial acetic acid, in distilled water) 
and counted in a standard haemocytometer chamber. Cell 
counts were performed in duplicate.
2.2.2 Monocyte purification and macrophage culture
Numerous methods have been employed for the puri­
fication of monocytes from peripheral blood. Monocytes can 
be separated from lymphocytes by adherence to tissue 
culture dishes (Herscowitz et al. 1981) . This technique 
has been widely applied owing to its simplicity and speed 
of performance. Other techniques for monocyte purification 
include density gradient centrifugation in Percoll (Feige 
et al, 1982) and centrifugal elutriation (Andreesen et al.
1990) . In the present studies, the adherence method was 
used.
Aliquots of the cell suspension containing 3 x 10s 
mononuclear cells were added to 35mm diameter tissue 
culture grade petri dishes containing 2,5 ml BMESS 
supplemented with 10% autologous serum, 100 ,u g/ml 
streptomycin (Sigma) and 100 IU/ml penicillin (Sigma). 
When kept in culture for a length of time, these monocytes 
develop general features of macrophages (Zuckerman et al,
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1979 ; Johnstone, 1988) . It is well known that culture
conditions may have a profound influence on the monocyte 
differentiation process and macrophage function in vitro. 
For example, monocytes cultured on fibronectin or collagen 
coated surfaces can modify the long term differentiation 
of monocytes (Kaplan and Gaudernack, 1982). Musson (1983) 
observed that monocytes cultured in vitro displayed 
changes dependent on the concentration of autologous serum 
and the length of time in culture, judged by several 
criteria. Various other functional, metabolic and 
morphological alterations associated with the terminal 
maturation of monocytes into macrophages in vitro. have 
been investigated. Increases in lysosomal enzymes (Yatziv 
et al, 1978; Musson et al, 1980), in cytotoxicity 
(Hammerstrom, 1979; Rinehart et al, 1979), in transferrin 
receptors (Andreesen et al. 1986; Hirata et al, 1986; 
Taetle et al. 1986) and in size and metabolism (Johnson et 
al, 1977; Zuckerman et al, 1979) have been reported. In 
view of the fact that macrophages are sensitive to the 
culture environment once removed from their natural 
location, it was necessary to optimize conditions for 
their cultivation. For the purpose of most of the 
experiments performed, macrophages were most conveniently 
maintained on 35mm diameter petri dishes at plating 
densities of 3 x 106 mononuclear cells per dish. The 
exclusion of serum resulted in detachment of the macro­
phages from the dishes after 2 to 3 days and a reduction 
in cell viability as assessed by trypan blue exclusion
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[chapter 2.3.2] . Similar results were obtained upon the 
addition of fetal calf serum to the culture medium. 
Although a number of investigators have successfully- 
cultured macrophages jjj vitro by using fetal calf serum, 
Johnson and co-workers (1977) reported that fetal or 
newborn calf, dog and horse sera did not support monocyte 
cultures for longer than 2 to 4 days. In the present 
studies, macrophages were maintained in 10% autologous 
serum. The cells were then incubated for a period of 8 
days at 37°C in an atmosphere of 5% C02. It has been shown 
that monocytes kept in culture for 3 to 10 days develop 
the general features of tissue macrophages (Schlesinger et 
al. 1984) . The number of cultured monocytes per dish could 
not be quantitated accurately. However, it was ensured 
that the plating density of mononuclear cells in each 
petri dish was the same in all subsequent experiments 
performed. Furthermore, to ensure successful cell culture 
all reagents were sterilized by filtering or autoclaving 
and all procedures were carried out with the use of a 
sterile hood.
2.2.3 Identification of cultured monocytes
2.2.3.1 Morphology and Photography
Monocytes obtained from haemochromatotic patients and 
normal subjects were cultured under identical conditions 
as described above [chapter 2.2.2]. Morphologic charac­
teristics were assessed by phase contrast microscopy and 
photographed with an inverted Olympus PM 6 Camera (Tokyo)
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attached to the phase contrast microscope (Olympus CK, 
Tokyo) . After 12 to 24 hours in culture the monocytes 
assumed characteristic features of macrophages. The 
macrophages were well spread, round to oval with some 
cells developing cytoplasmic extensions. After 8 days in 
culture the macrophages were heterogenous in terms of 
morphology, nucleation and density and the mean cell 
diameter ranged between 3 0 to 40 /xm (figures 1 and 2) . For 
more accurate identification of monocytes, techniques 
demonstrating cytochemical staining characteristics and 
phagocytic abilities are preferred.
2.2.3.2 Esterase staining
The non-specific esterase staining method was 
performed as described by Yam and co-workers (1971). The 
monocytes stained reddish-brown and lymphocytes green. 
More than 90% of the adherent cells stained positively 
with non-specific esterase.
2.2.3.3 Phagocytosis
The phagocytic properties of monocytes were assessed 
by phagocytosis of Candida albicans (Miller, 1969). The 
yeast particles were inoculated in brain-heart infusion 
liquid medium and incubated at 37°C for 24 hours. The cell 
suspension was heat inactivated at 100°C for 30 minutes and 
then washed in phosphate buffered saline (PBS). The cells 
were counted in a haemocytometer chamber and 0,5 ml (109 
yeast cells per ml) was incubated with 0,5 ml autologous 
serum at 37°C for 1 hour. The suspension was added in a 
ratio of 100 yeast cells per monocyte to the petri dishes
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Figure 1: Phase contrast photography showing the
morphologic characteristics of 8 day cultured 
macrophages derived from a normal subject.
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Figure 2: Phase contrast photography showing the
morphologic characteristics of 8 day cultured 
macrophages derived from a patient with 
haemochromatosis.
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containing the adherent population and incubated at 37°C 
for 1 hour. Thereafter the dishes were washed 3 times with 
PBS and the number of phagocytic cells counted. More than 
80% of the adherent monocytes phagocytosed yeast par­
ticles .
2.3 ASSESSMENT OF CELL VIABILITY
2.3.1 Introduction
The viability of cells in culture can be assessed by 
cytological staining e.g. exclusion of trypan blue dye 
from viable cells. This method relies upon the integrity 
of cell membranes as a measure of cell survival. Other 
procedures based upon protein synthesis are probably 
better as these reflect directly on metabolic activity. 
The morphological and functional characteristics of a cell 
are largely determined by their macromolecular consti­
tuents such as proteins, carbohydrates and lipids, all of 
which are ultimately controlled by the nucleic acids. In 
in vitro tracer techniques, the addition of labelled 
nucleosides or amino acids to cells may be useful in 
analyzing the renewal of these macromolecular components. 
This study aimed to investigate the metabolic integrity of 
the adherent macrophage population after 8 days in 
culture. For this purpose the uptake of the tritiated (3H) 
nucleoside, uridine, into RNA was determined concurrently 
with the incorporation of 3H-leucine into protein of 
cultured macrophages derived from both haemochromatotic 
patients and healthy volunteers. The assessment of these
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two functional parameters was considered important to 
clarify as a preliminary step to any subsequent studies to 
be undertaken on the cultured macrophages.
2.3.2 Subjects and Methods
For each study 2 haemochromatotic patients undergoing 
phlebotomy therapy and 2 normal volunteers were included. 
300 ml citrated blood was separated by Ficoll-hypaque 
centrifugation to yield total mononuclear cells [chapter 
2.2.1] . The resulting cell suspension was then added in 
aliquots of 3 x 10s cells per 35mm petri dish containing
2,5 ml BMESS with 10% autologous serum and antibiotics. 
The cells were incubated at 37°C under 5% C02 in air. All 
experiments were performed on "mature macrophages" after 
8 days in culture. The cellular integrity of the initial 
mononuclear cell preparations and cultured adherent cells 
was firstly determined by exclusion of trypan blue 
(Mishell and Shiigi, 1980) . The nonadherent cells and 
culture medium were removed by repeated washings with PBS 
and the adherent cells were gently removed using a rubber 
policeman. A solution of trypan blue in normal saline (1%) 
was added to a sample of cells and an aliquot was 
transferred to a standard haemocytometer chamber. Viable 
and non-viable (blue stained) cells were counted and the 
procedure was repeated to ensure accuracy. Greater than 
98% of the adherent cells excluded trypan blue both at the 
outset and at the completion of the experimental time 
periods. More than 90% of the cells stained positively
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with non-specific esterase and phagocytosed yeast 
particles. Culture dishes were set up in quadruplicate for 
each time interval. Control dishes containing no cells 
were also included. The culture medium and any nonadherent 
cells were removed from the petri dishes on day 8 by 
washing 3 times with PBS. Two ml of prewarmed RPMI medium 
containing 10% fetal calf serum was added to each dish 
containing adherent macrophages and to the dishes 
containing no cells and then incubated for 1 hour at 37°C. 
For the uridine uptake study, 2 /xCi of [5,6 - 3H] uridine 
(40 Ci/mmol, Amersham) was added to each dish. In a 
separate set of experiments, 20 of L - [4.5-3H] leucine 
(143 Ci/mmol, Amersham) was added per dish so that the 
final concentration of radioactivity was 0,37 MBq/ml. The 
dishes were incubated at 37°C in a 5% C02 atmosphere. At 
timed intervals, the supernatant extracellular fluid was 
discarded and the adherent cells were washed 3 times with 
ice-cold PBS. One ml of a 0.2% Triton-100 and 0,1 M sodium 
hydroxide solution was added to each dish and after 
incubation for 5 minutes at room temperature, the lysed 
macrophages were transferred to test tubes. Each dish was 
washed twice more with 500 /il of the detergent solution. 
To each tube, containing 2 ml of resultant lysate and 
washes, was added either 100 /il of unlabelled uridine (1 
mg/ml) or 100 j i l of bovine serum albumin (1%) for the 
leucine uptake study. The lysate was made up to 5% 
trichloroacetic acid and the tubes were vortexed briefly 
and chilled on ice. The precipitates were collected on
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glass microfibre discs (Whatman) using a Millipore filter 
apparatus. Each tube was washed twice more with ice-cold 
5% trichloroacetic acid. The filter discs were immersed in 
5 ml scintillation cocktail and the trichloroacetic acid- 
precipitable radioactivity was measured in a Packard Tri- 
carb Liquid Scintillation Spectrometer (Model 3375, 
Illinois, USA). Corrections were made for background 
counts by counting unused discs. Results were expressed as 
mean counts per minute (cpm) ± standard error (SE) of 3H- 
uridine and 3H-leucine incorporated into RNA and protein 
respectively, per dish.
2.3.3 Results
The experimental findings for the uridine uptake 
study are depicted in figure 3. The incubation of 8 day- 
old cultured macrophages with 3H-uridine led to a steady 
accumulation of the pyrimidine base over a time period of 
8 hours. It can be seen that the extent of uridine incor­
poration by haemochromatotic macrophages was comparable to 
that noted in normal macrophages.
The results of representative experiments for the 
leucine uptake study (figure 4) demonstrate a linear 
uptake of the amino acid by the cultured macrophages with 
respect to time. At 3 hours, a three-fold increase in the 
3H-leucine was detected in cells from both normal 
individuals and patients with haemochromatosis. The 
results reported here show that in general, the time
70
U
rid
in
e 
in
co
rp
or
at
io
n 
(3
H
cp
m
x1
03
)
Figure 3: The time-dependent uptake of 3H-uridine by 8
day cultured macrophages derived from 2 
haemochromatotic (HCT) patients (•) and 2 
healthy subjects (o). Each point represents 
the mean ± SE of quadruplicate culture 
dishes.
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Figure 4: Time course of the incorporation of 3H-leucine
in haemochromatotic (•) and normal (o) 
macrophages after 8 days in culture. Each 
point represents the mean ± SE of quadruplicate 
dishes.
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course for the incorporation of 3H-leucine into newly 
synthesized protein was very similar for both study groups 
investigated.
It was decided not to pursue these studies further 
based on the essential similarities observed in the graphs 
of both groups.
2.3.4 Discussion
The investigation of the incorporation of precursor 
molecules into RNA and protein was initiated to assess 
whether macrophages maintained in culture for 8 days still 
attained metabolic activity. As discussed before [chapter 
2.2.2] numerous studies on human monocytes have revealed 
biochemical, morphologic and functional alterations during 
their jj} vitro maturation. In the current investigations, 
the addition of a precursor amino acid such as leucine to 
the incubating medium of macrophages relatively deprived 
of nutritious agents after 8 days in culture, resulted in 
a progressive increase in the total protein synthesis of 
the adherent population. Similarly the RNA synthetic rates 
progressed linearly with respect to time upon addition of 
uridine. It was also observed that the uptake of uridine 
and leucine for nucleic acid synthesis and protein 
synthesis respectively, was similar for the study groups 
investigated.
In conclusion, the present results indicate that 
cultured macrophages accept uridine and leucine from the 
extracellular environment and retain their ability to
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synthesize RNA and protein after 8 days in culture, 
showing that the cells are still metabolically viable. 
Furthermore, these data show that whatever changes occur 
in monocytes upon adherence, the rates of protein 
synthesis and RNA synthesis are not different between 
normal and haemochromatotic cells by day 8.
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SECTION 2
CHAPTER 3
TRANSFERRIN-IRON-MACROPHAGE INTERACTIONS
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3.1 INTRODUCTION
The relative paucity of iron deposition in cells of 
the RES in HLA-linked haemochromatosis as compared with 
parenchymal cells of affected tissues (Valberg et al. 
1975; Brink et al, 1976; McClaren, 1989), has long been 
noted. Possible defects in RE iron uptake and storage have 
been extensively investigated, but to date not been fully 
clarified.
Monocyte-macrophages and other cells of the RE system 
play a central role in the storage of iron, which is 
mostly acquired from the phagocytosis of senescent red 
cells (Bothwell et al, 1979) . The presence of receptors 
for diferric transferrin on human macrophages (Andreesen 
et al, 1983; Adams and Hamilton, 1984; Andreesen et al, 
1984; Baynes et al. 1987b) suggests an alternative source 
of iron for RE cells. The relative absence of RE iron in 
haemochromatosis has stimulated interest in a possible 
abnormality in the uptake of transferrin iron by RE cells. 
Such a defect could result in a high level of iron 
absorption and plasma transferrin saturation with the 
deposition of excess iron in parenchymal tissues (Cook et 
al. 1973) . Several studies have been unable to support 
this hypothesis. In vitro studies on peripheral blood 
monocytes have shown no difference in transferrin iron 
uptake between phlebotomised patients with normal body 
iron stores and normal control subjects (Jacobs and 
Summers, 1981; Sizemore and Bassett, 1984). However, a 
significant reduction in transferrin iron uptake by
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monocytes has been reported in both treated (McClaren et 
al. 1979) and iron-loaded haemochromatosis patients 
(Sizemore and Bassett, 1984). The differences observed in 
transferrin iron uptake in haemochromatosis by various 
authors has led to investigations into abnormalities in 
transferrin receptor binding and transferrin receptors. 
Studies have failed to reveal any differences in the 
properties of transferrin receptors on cultured fibro­
blasts and lymphocytes (Ward et al, 1984a) or macrophages 
(Baynes et al, 1989) derived from haemochromatotic 
patients. Contradictory evidence demonstrating increased 
transferrin receptor expression on monocytes from patients 
with hereditary haemochromatosis has been provided by 
Bjorn-Rasmussen and colleagues (1985). It is clear that 
the available data on transferrin-iron-macrophage 
interactions in HLA-linked haemochromatosis is not 
consistent.
In the present in vitro study, radiolabelled diferric 
transferrin uptake was examined in cultured macrophages in 
order to determine whether the behaviour of haemo­
chromatotic macrophages differed from normal macrophages.
3.2 SUBJECTS AND METHODS
The study group comprised 3 haemochromatotic patients 
undergoing phlebotomy therapy and 3 healthy volunteers. 
The serum iron concentration, total iron-binding capacity 
and serum ferritin concentration were assessed in all 
subjects according to methods described in chapter
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2.l.l.2. Student's t tests were applied to compare the 
means of the biochemical measurements. Doubly labelled 
diferric transferrin was prepared according to established 
methods. Human transferrin was obtained from Sigma (St 
Louis, Missouri, USA), 59Fe as FeCl3 and 125I as Bolton and 
Hunter reagent were from Amersham (Buckinghamshire, UK). 
Diferric transferrin was prepared by labelling transferrin 
with 59Fe as described by Baynes and co-workers (1987b). 
The degree of iron saturation was evaluated by spec­
troscopy and on 6 M urea polyacrylamide gel electro­
phoresis using the method of Makey and Seal (1976) . The 
59Fe labelled differic transferrin was then iodinated with 
12SI by the Bolton and Hunter Method (1973) . The end concen­
tration of diferric transferrin was determined by radial 
immunodiffusion. To remove any contaminating iron, all 
buffers and media were prepared with distilled water that 
had been extracted with 200-400 mesh Chelex 100 resin 
(Biorad, Richmond, California, USA).
Peripheral blood mononuclears were isolated from 300 
ml citrated blood and cultured as previously described 
[chapter 2.2]. Cultures were established at 37°C in a 5% 
C02 incubator by accurately plating 3 x 10s cells onto 35mm 
diameter tissue culture dishes containing 2,5 ml BMESS 
with 10% autologous serum and antibiotics. Both dose and 
time response studies were performed on the eighth day of 
culture. At this time, the viability of the adherent cells 
was more than 98% as judged by trypan blue exclusion, 
while more than 90% stained positively with non-specific
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esterase and phagocytosed yeast particles. The culture 
medium and any nonadherent cells were removed from the 
petri dishes and the dishes were washed 3 times with PBS. 
Thereafter, 2 ml RPMI medium and 1% bovine serum albumin 
were added and the dishes incubated for 1 hour at 37°C. 
After the preincubation period, doubly labelled diferric 
transferrin was added to each dish in specific amounts 
(see figure legends) for the dose response studies, while 
a constant amount was added in the time response experi­
ments. Control dishes containing no cells were included in 
each study. Petri dishes containing a 100-fold excess of 
unlabelled diferric transferrin were also set up for each 
dose and time component. The dose-dependent diferric 
transferrin studies were performed over 90 minutes, 
whereas various time intervals were chosen for the time- 
dependent studies. On completion of the incubation at 37°C 
/ 5% C02 atmosphere, the supernatants were removed and the 
adherent cells were washed 3 times with ice-cold PBS. One 
ml of a 0,2% Triton-100 and 0,1 M sodium hydroxide 
solution was added to each dish and incubated for 5 
minutes at room temperature. The cellular lysates were 
collected in test tubes. Two additional washes of the 
petri dishes with the detergent solution were also 
collected. The resultant suspension of disrupted cells was 
counted for 125I and S9Fe activity in a Packard Autogamma 
counter (Model 5650, Packard Instruments, Downers Grove 
Illinois, USA) in order to determine diferric transferrin 
and iron uptake respectively. Appropriate corrections were
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made for cross counting and any non-specific interactions 
between the transferrin and the petri dishes. The total 
experimental binding less the counts obtained from dishes 
without cells and less the counts obtained from dishes 
which also had a 100-fold excess of unlabelled diferric 
transferrin was calculated in order to obtain cell 
specific binding. The results are expressed as pmoles 
transferrin or iron uptake per mg of protein. The results 
for the time response studies are given as means and 
standard deviations for the experiments performed on 3 
patients with haemochromatosis and 3 normal subjects. 
(Within an experiment determinations were carried out in 
triplicate). Group means at each time point were compared 
by using Student's t test. The protein content per dish 
was assayed according to the dye binding method (Biorad, 
Richmond, California, USA) using bovine serum albumin as 
standard. Here the mean figure of quadruplicate dishes 
containing cells derived from each subject was determined.
3.3 RESULTS
The biochemical features of the study participants 
are summarized in Table I. The mean serum ferritin (SF), 
serum iron (SI) and transferrin saturation concentrations 
of haemochromatotic patients were within or slightly below 
the normal range as a result of a vigorous phlebotomy 
programme. There were no significant differences between 
normal and haemochromatotic groups when Student's t tests 
were applied to all biochemical measurements.
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(SF) , transferrin iron binding capacity (TIBC)
TABLE I: Mean and SD for serum iron (SI) , serum ferritin
and % transferrin saturation for 3 normal 
subjects and 3 patients with haemochromatosis 
undergoing phlebotomy therapy. The level of 
significance of difference between measurements 
as determined by Student's t test is shown.
STUDY GROUP SI (ucr/dL) SF (ucr/1) TIBC (ucr/dL) %TFSAT
Normal subjects
1 82 35 271 30.3
2 82 99 280 29.3
3 153 52 327 46.8
Mean 105.7 62 292.7 35.5
± SD 41 33.2 30.1 9.8
HCT oatients (treated)
1 49 11 195 25.1
2 104 16 316 32.9
3 131 21 460 28.5
Mean 94.7 16 323.7 28.8
± SD 41.8 5 132.7 3.9
t-value * 0.33 2.38 0.395 1.94
p value * 0.76 0.14 0.71 0.12
Normal range 60-150 20-250 250-400 20-50
* Normal and haemochromatotic (HCT) groups statistically 
equivalent by Student's t test for all parameters.
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The results of the dose-dependent uptake of diferric 
transferrin by macrophages in patients with hereditary 
haemochromatosis and normal control subjects are shown in 
figure 5. Concentrations ranging between 5 to 250 pmoles 
of labelled diferric transferrin were added to each petri 
dish. During the 90 minute incubation period the specific 
uptake of the protein proceeded in a linear fashion up to 
approximately 60 pmoles of added transferrin and there­
after a plateau was reached. This was observed in macro­
phages from both study groups. The binding characteristics 
were not assessed in this study.
Based on the results of the dose response study, a 
constant amount of 50 pmoles of labelled differic trans­
ferrin was added to each dish in the time-dependent uptake 
studies that followed. The measurements of transferrin 
uptake by macrophages from both study groups and their 
comparative statistical values are listed in Table II. 
Figure 6 shows the uptake of 125I-diferric transferrin by 
macrophages in the 3 healthy subjects and 3 patients with 
haemochromatosis. The time course study (figure 6) 
revealed that there was a progressive uptake of trans­
ferrin at first and then maximal uptake was achieved by 90 
to 180 minutes. The mean transferrin uptake by haemo- 
chromatotic macrophages was about 1.9 times greater at 1 
hour (p = 0.003) and 1.4 times greater at 1.5 hours (p = 
0.009) than normal macrophages (Table II) . There was no 
significant difference between normal subjects and 
haemochromatotic patients with respect to mean transferrin 
uptake at 4 hours (p = 0.053).
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Figure 5: The dose-dependent uptake of diferric
transferrin by haemochromatotic (•) and normal 
(o) cultured macrophages. The duration of 
incubation in the presence of labelled 
diferric transferrin was 90 minutes. Each dose 
point represents the mean value of triplicate 
culture dishes.
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protein) at various time intervals by cultured 
macrophages from 3 normal subjects and 3 
treated haemochromatotic (HCT) patients. Group 
means at each time point were compared by 
Student's t test.
TABLE II: Mean and SD for transferrin uptake (pmole/mg
TIME (hr) NORMAL (n=3) HCT (n=3) t-value p value
0 ,.5 1 .45 + 0 .5 3 .08 + 0 .43 4 .3 0 . 013
1.. 0 2 . 54 + 0 .26 4 . 95 + 0 .43 8 . 4 0 . 003
1.. 5 3 . 63 + 0 .27 5 .24 + 0 .34 6 . 0 0 . 009
2 .0 4 .13 ± 0 .31 5 .51 + 0 .25 5 .2 0 . 04
3 . 0 4 .45 + 0 .43 5 .97 ± 0 .41 3 . 9 0 .03
4 . 0 4 .41 + 0 .,59 5 .81 ± 0 .66 2 .7 0 .053*
* Difference not statistically significant.
Differences were regarded as significant when p < 0.05. 
Although visually a difference is observed, the small 
number of subjects studied make the t-values 
unreliable.
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Figure 6: The time-dependent uptake of transferrin per
mg of protein by cultured macrophages obtained 
from 3 haemochomatotic patients (•) and 3 
normal subjects (o) . Doubly labelled diferric 
transferrin (50 pmol) was added to each petri 
dish. Each time point represents the mean and 
standard deviation from 3 experiments.
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In the studies evaluating the uptake of S9Fe-diferric 
transferrin by macrophages, a linear increase in iron 
uptake was noted (figure 7). This pattern was observed in 
all study participants. The measurements for iron uptake 
by macrophages from both study groups and their compara­
tive statistical values are shown in Table III. There was 
no difference in the mean cellular iron uptake at 30 
minutes between normal subjects and haemochromatotic 
patients (p = 0.34), however iron uptake by haemochroma­
totic cells was about 2.7 times lower at 2 hours (p = 
0.01) and 2.1 times lower at 5 hours (p = 0.006) than 
normal cells (Table III).
3.4 DISCUSSION
The current in vitro study was aimed at comparing 
transferrin and transferrin iron handling by peripheral 
blood monocytes derived from 3 treated haemochromatotic 
and 3 healthy subjects. The objective of treatment in 
patients with haemochromatosis is to reduce body iron 
stores by repeated phlebotomy. After venesection, storage 
iron is mobilized to satisfy erythroid marrow require­
ments. The results shown in Table I indicate that, at the 
time of the study, excess iron had been removed from the 
patients with haemochromatosis and the concentration of 
serum iron did not differ significantly from the control 
group. The serum ferritin concentration in these patients 
was bordering at the level generally accepted as 
indicating depleted iron stores (Bothwell et al, 1979),
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TABLE III: Mean and SD for iron uptake (pmole/mg protein)
at various time intervals from 3 normal 
subjects and 3 treated haemochromatotic (HCT) 
patients. Group means at each time interval 
were compared by Student's t test.
TIME (hr) NORMAL (n=3) HCT (n=3) t-value p value
0.5 21 .16 ±  11.93 12.51 + 6.37 - 1.1 0 .34*
1.0 45 .36 ±  6.22 20.62 + 11.08 - 3.4 0.04
1.5 74 .23 ±  11.61 27.20 + 16.51 - 4.0 0.02
2.0 94 .97 ±  11.73 35.61 + 19.74 - 4.5 0.01
3.0 113 . 63 ±  14.16 56.73 ± 15.36 - 4.7 0.009
5.0 150 .38 ±  13.87 71.49 + 19.62 - 5.7 0.006
* Difference not statistically significant.
Differences were regarded as significant when p < 0.05. 
Although visually a difference is observed, the small 
number of subjects studied make the t-values 
unreliable.
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Figure 7 : The uptake of iron by haemochromatotic (•) and
normal (o) cultured macrophages as a function 
of time. Doubly labelled diferric transferrin 
(50 pmol) was added to each culture dish. 
Each time point represents the mean and 
standard deviation from 3 experiments.
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but was not significantly lower than in the control group 
(t = 2.38, p = 0.14).
The results obtained in the in vitro experiments on 
transferrin-iron-macrophage interactions indicate that 
both normal and haemochromatotic macrophages possess a 
mechanism for the uptake of diferric transferrin. Uptake 
by haemochromatotic macrophages was 1.9 times greater (at 
1 hour) and 1.4 times greater (at 1.5 hours) than uptake 
by normal macrophages (Table II & figure 6) . While in this 
study binding characteristics were not evaluated, previous 
work has provided evidence for the presence of diferric 
transferrin receptors on macrophages (Andreesen et al. 
1983 & 1984; Adams and Hamilton, 1984; Baynes et al,
1987b; Testa et al. 1989) . Studies have shown no signi­
ficant difference between the binding affinities of 
transferrin receptors on macrophages from haemochromatotic 
patients and normal subjects (Ward et al. 1984a; Baynes et 
al, 1989) . The greater increase in uptake of diferric
transferrin by the haemochromatotic macrophages observed 
in the present study may have been a secondary response to 
a low intracellular iron pool and an increased transferrin 
receptor expression through the IRP mechanism (section 1, 
chapters 1.2.5.3 and 1.3.6.2). Bjorn-Rasmussen and 
colleagues (1985) demonstrated an increased transferrin 
receptor expression on circulating monocytes from 12 
haemochromatotic patients, but there was no correlation 
between the degree of patient iron overload and the number 
of transferrin receptors on monocytes. Although no
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significant difference was found between normal subjects 
and haemochromatotic patients in their biochemical values 
(Table 1), it is possible that the observed difference in 
their uptake of diferric transferrin represents a real 
difference since studies (Testa et al. 1989; Byrd and 
Horwitz, 1993) have shown that transferrin receptor 
expression is upregulated by iron.
In the final part of the current study, the uptake of 
iron derived from transferrin was compared in normal and 
haemochromatotic macrophages. The uptake of transferrin 
iron was 2.7 times lower (at 2 hours) and 2.1 times lower 
(at 5 hours) when compared to normal macrophages (Table 
III & figure 7) despite the higher transferrin uptake by 
macrophages from patients with haemochromatosis (figure 
6) . These findings may be of physiological importance 
since the RE system in hereditary haemochromatosis does 
not normally retain iron (Valberg et al, 1975; Brink et 
al. 1976) . The observed differences in transferrin iron 
uptake may be the result of a possible abnormality in 
post-receptor events. In this regard, abnormalities of 
either iron release or iron storage could account for this 
difference. There is some evidence of defective iron 
release in haemochromatosis. The investigations by Fillet 
and colleagues (1989) into iron kinetics in the RE system 
of humans using heat-damaged erythrocytes labelled with 
radioactive iron, identified an early iron release phase, 
from haem catabolism, and a late release phase, from RE 
iron stores. Early radioiron release was increased in
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patients with haemochromatosis compared with subjects with 
similar iron stores. This was true both for patients with 
limited and markedly increased iron stores. A similar 
mechanism could explain why iron uptake by macrophages 
from haemochromatotic patients appeared to be less than 
controls in the present study, as iron, entering on 
transferrin, is more rapidly released than in normal 
macrophages. The relative paucity of stored iron in the RE 
system of haemochromatotic individuals, has also led many 
investigators to believe that synthesis of ferritin may be 
defective in macrophages. Many studies do not support this 
hypothesis. No defect in the ferritin synthesis of these 
cells has been found in haemochromatosis patients (Jacobs 
and Summers, 1981; Bassett et al. 1982) . However, a recent 
report by Gordeuk and co-workers (1992) demonstrated an 
impaired release of tumor necrosis factor-a (TNF-of) from 
cultured blood monocytes from homozygous haemochromatotic 
patients. Of relevance to the present study is the authors 
suggestion that a reduced amount of TNF-a may result in 
inhibition of ferritin synthesis and enhanced release of 
iron from monocytes.
In summary, the current study constituted an attempt 
to identify any differences in transferrin and transferrin 
iron uptake by cultured m a c ro p h a g e s  b e tw e e n treated 
haemochromatotic patients and normal subjects. Cells from 
both groups were shown to take up diferric transferrin. 
Transferrin uptake was significantly higher in macrophages 
from patients with haemochromatosis. This was thought to
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be due to a secondary effect to low intracellular iron 
levels or possibly due to increased transferrin receptor
expression. The iron uptake was shown to proceed at a
lower level in the cells from patients with haemo-
chromatosis. An altered ferritin synthesis, ferritin
content or enhanced release of iron by various mechanisms 
may be amongst several possible explanations for this 
effect. It must be emphasized that the results reported 
here represent a small number of subjects and more studies 
are needed on a larger group in order to verify these 
findings. Furthermore, while the results are suggestive of 
a deranged iron homeostasis in haemochromatotic RE cells 
in vitro, it should be noted that the uptake of trans­
ferrin iron by mononuclear cells represents a relatively 
insignificant pathway in the jja vivo situation. Therefore, 
its relationship to the pathogenesis of HLA-linked 
haemochromatosis remains questionable.
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SECTION 3
FERRITIN mRNA EXPRESSION IN HAEMOCHROMATOTIC MACROPHAGES
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SECTION 3
CHAPTER 4
MATERIALS AND METHODS
94
4.1 INTRODUCTION
The present chapter is concerned with various 
molecular biological techniques. Three methods are 
presented for the extraction of RNA from human cultured 
macrophages. The preparation of plasmid DNA, restriction 
digestion, radiolabelling of DNA and hybridization are 
also described here. Many of the techniques, shown to have 
worked in this laboratory, have been modified or expanded 
to suit this particular study. The methodologies explored 
by Dr.S.E. Lapinsky in his study on reticuloendothelial 
messenger RNA in inflammatory states (1989) provided a 
valuable stepping stone for the practical aspects con­
cerned in this chapter.
4.2 PREPARATION OF RIBONUCLEIC ACID
4.2.1 RNA isolation methods
In this section techniques are presented for the 
isolation of RNA from cultured macrophages. The extraction 
of undegraded ribonucleic acid requires that ribonuclease 
(RNase) contamination be minimized. To ensure RNase 
removal, all glassware was baked at 250°C for 4 hours; 
disposable pipette tips were autoclaved at 120°C for 30 
minutes; whenever possible, stock solutions were steri­
lized by treatment with 0,1% (v/v) diethylpyrocarbonate
(DEPC), an effective inhibitor of RNase, and autoclaved 
for 30 minutes at 120°C and gloves were worn during 
handling of all items and solutions in contact with the 
RNA. The stability of RNA was further ensured by keeping
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all solutions ice-cold. Three methods were assessed for
the isolation of RNA from macrophages cultured in vitro. 
The isolation of blood mononuclear cells and the culture 
of monocytes was followed as described in section 2, 
chapter 2.2. All RNA extraction procedures were performed 
on the eighth day of culture.
The guanidinium isothiocvanate method was first 
investigated for the isolation of RNA. Guanidinium salts 
are potent chaotropic denaturants of proteins, including 
ribonucleases. Cox (1968) described the use of guanidinium 
chloride for the isolation of RNA from ribosomes in which 
ribonucleases were denatured. For tissues with high RNase 
activity such as the pancreas, Chirgwin and co-workers 
(1979) made use of guanidinium thiocyanate as an effective 
deproteinizing agent. In the present study, the isolation 
of total RNA from macrophages was performed after modifi­
cations of the method of Chomczynski and Sacchi (1987). 
After removal of the medium and any nonadherent cells from 
the 35mm diameter tissue culture dishes, the dishes were 
washed 3 times with PBS. 200 f i l of the denaturant solution 
(guanidinium isothiocyanate 4 M; sodium citrate 25 mM; 
sodium lauryl sarcosine 0,5% (w/v); S-mercaptoethanol 
0,1 M) was added to each dish. The surface was scraped 
with a rubber policeman and the dishes were washed with an 
additional 200 f i l of denaturant solution. One ml aliquots 
were transferred to 2,2 ml Eppendorf tubes. To each 1 ml 
of solution was added 100 f i l of sodium acetate (2 M, pH 
4), 1 ml of DEPC-saturated phenol containing 8-hydroxy-
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quinoline (0,1%) and 200 /j.1 of a chloroform : isoamyl- 
alcohol solution (49:1) . The contents of each tube were 
thoroughly mixed by vortexing for 30 seconds and then kept 
on ice for 15 minutes. The samples were centrifuged at 10 
000 g for 20 minutes at 4°C. The upper aqueous phase, which 
contained the RNA, was carefully collected in 2,2 ml 
Eppendorf tubes and the phenol phase containing proteins 
and DNA was discarded. The RNA in the final aqueous phase 
was precipitated by adding an equal volume of isopropanol 
and chilled at -70°C overnight. The RNA was sedimented at 
10 000 g for 20 minutes at 4°C and the pellet was resus­
pended in 75% ethanol. After centrifugation, the pellet 
was vacuum dried for 15 minutes and dissolved in a 
suitable volume of DEPC-treated water (15 to 30 i^l) .
The lithium chloride method for RNA isolation was 
next evaluated. The procedure, as described by LeMeur and 
colleagues (1981) , was adapted for the extraction of RNA 
from cultured monocytes. Two ml of homogenisation buffer 
(lithium chloride 3 M; urea 6 M; sodium acetate 10 mM; 
heparin 200 pig/ml; sodium dodecyl sulfate 0,1% (w/v) ; S- 
mercaptoethanol 1%) was added directly to each petri dish 
containing adherent macrophages. The cells were scraped 
off the dishes with a rubber policeman and the pooled 
contents of 3 dishes were homogenized using an Ultra- 
Turrax homogenizer. The resultant solution was aliquotted 
as 2 ml volumes into 2,2 ml Eppendorf tubes and left 
overnight at 4°C. The samples were then centrifuged at 10 
000 g for 20 minutes at 4°C. The supernatant was carefully
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removed and the pellet was washed 3 times by centri­
fugation with 2 ml of washing buffer (lithium chloride 4 
M; urea 8 M; S-mercaptoethanol 1%). The aqueous solution 
was removed and the pellet dissolved in 400 pil of solu­
bilization buffer (sodium acetate 50 mM; sodium dodecyl 
sulfate 1% ; S-mercaptoethanol 1%) . Each sample was 
extracted twice by the addition of 400 /xl phenol (Tris- 
EDTA saturated, pH 8,0) and 400 /il chloroform : isoamyl- 
alcohol (24:1). After thorough mixing by vortexing for 30 
seconds, the samples were centrifuged at 10 000 g for 20 
minutes at 4°C to separate the phases. The upper aqueous 
was carefully removed and to this an equal volume of 
isopropanol was added. After mixing, the samples were 
incubated at -70°C overnight. The RNA was pelleted once 
more by centrifugation, washed in 75% ethanol, vacuum 
dried and dissolved in DEPC-water.
The NP40-urea-SDS method was lastly investigated. 
This technique, suitable for the preparation of cyto­
plasmic RNA from tissue culture cells, was described by 
Gough (1988). The macrophages with their growth medium 
were harvested directly from the petri dishes by gently 
scraping the surface with a rubber policeman. The cells 
were pelleted in 1,5 ml Eppendorf tubes by centrifugation 
at 800 g for 5 minutes. The medium was removed by 
aspiration and 200 /xl of an ice-cold Tris-HCL 10 mM (pH 
7,5); magnesium chloride 1,5 mM; Nonidet P-40 0,65% (v/v) 
solution was added to each pellet. After vortexing 
vigorously, the preparation was centrifuged at 800g for 5
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minutes at 4°C to remove nuclei. To 200 f i l aliquots of the 
aqueous supernatant was added 2 00 /.tl of a solution 
containing urea 7 M; sodium dodecyl sulfate 1% ; sodium 
chloride 0,35 M; Tris-HCL lOmM (pH 7,5) and EDTA 10 mM. 
After mixing, 400 (i 1 phenol : chloroform : isoamylalcohol 
(50:50:1) was added to each Eppendorf tube and then 
vortexed for 30 seconds. The samples were incubated on ice 
for 15 minutes and then centrifuged for 10 minutes at 
10000 g. The RNA was recovered from the aqueous phase by 
precipitation with 2,5 volumes of 95% ethanol and chilled 
at -70°C overnight. The samples were centrifuged to 
sediment the RNA and the ethanol was evaporated by vacuum 
drying. The pellet was then dissolved in a small volume of 
DEPC-water. All RNA samples were stored at -20°C for future 
use.
Both the guanidinium thiocyanate and lithium chloride 
methods proved effective enough to provide good yields of 
RNA and the extracted RNA was pure and undegraded (see 
chapter 4.2.3, figures 9 and 10) . It is of paramount 
importance that all steps in the isolation of RNA are 
performed as quickly as possible. In this regard, the 
lithium chloride method is time-consuming whereas the use 
of guanidinium thiocyanate is a relatively simple proce­
dure permitting the rapid recovery of RNA from cultured 
cells. The NP40-urea-SDS method followed according to 
Gough (1988) was unsuccessful as evidenced by the 
electrophoretic pattern demonstrating the presence of 
degraded RNA [chapter 4.2.3, figure 11] . It is possible
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that the use of sodium dodecyl sulfate and urea were 
insufficiently effective as protein denaturants, although 
Gough (1988) was able to extract intact RNA from tissue 
culture cells and cell suspensions. The method of choice 
for the isolation of RNA from cultured macrophages for all 
future ifl vitro experiments, was the guanidinium thio­
cyanate-phenol-chloroform extraction.
4.2.2 Spectroscopic analysis
The RNA was quantitated spectrophotometrically by 
measuring the amount of ultraviolet (uv) irradiation 
absorbed at 260 nm and using the extinction coefficient of 
A = 1.0 for 40 ixg RNA/ml [1 cm light path] (Maniatis et 
al, 1982) . The absorbance was also recorded at 280 nm. The 
ratio of A260nm / A280nm is a useful indicator of the purity 
of samples. The presence of contaminating protein or 
phenol, which absorb at 280 nm, decrease the ratio. RNA 
preparations with an A260 /A280nm of 1,8 to 2,0 indicated that 
the samples were pure. An example of a spectrophotometric 
scan is given in figure 8.
4.2.3 Gel electrophoresis
All the RNA samples obtained by the extraction 
procedures described in chapter 4.2.1 were electrophoresed 
in a denaturing formaldehyde agarose gel according to 
Maniatis and co-workers (1982). A 1,5% agarose minigel was 
prepared by dissolving the agarose in water by heating in
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Figure 8: RNA extracted from 8 day cultured
macrophages was assessed by spectro- 
photometric scanning in the range of 220 
to 320 nm.
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a microwave oven. The solution was allowed to cool to 50 
to 60°C before adding formaldehyde to a 2,2 M final 
concentration. The agarose solution was poured into a gel- 
mold and well-forming combs were positioned. After 
setting, the gel was submerged in an electrophoresis 
apparatus containing MOPS running buffer (morpholino- 
propanesulfonic acid 0,2 M pH 7,0; sodium acetate 50 mM; 
EDTA ImM). The combs were then carefully removed. Before 
electrophoresis, 2 f i l of the RNA solution (containing 2 to 
6 iig) was denatured at 55°C for 15 minutes in 14,5 i l l of 
sample buffer (running buffer 1 pil; deionized formamide 
10 i l l ; formaldehyde 3,5 i l l )  . 2 i l l of loading buffer 
(glycerol 50% ; EDTA 1 mM; bromophenol blue 0,4%; xylene 
cyanol 0,4%) and 1 /il ethidium bromide (1 mg/ml) was added 
to each Eppendorf tube. The samples were carefully applied 
to individual wells and the gel was run at 75V for 
approximately 3 to 4 hours. The ethidium bromide stained 
bands were photographed on an ultraviolet trans­
illuminator. The integrity of the RNA was assessed by 
evaluation of the 28S and 18S ribosomal RNA (rRNA) bands 
and a ratio of 2 : 1 excluded degradation of the nucleic 
acid. Figure 9 represents the electrophoretic pattern of 
total RNA isolated from cultured macrophages by the 
guanidinium thiocyanate-phenol-chloroform method. A 
similar pattern was observed when RNA was extracted by the 
lithium chloride method (figure 10) . The RNA was separated 
according to its molecular weight and the presence of 28S 
and 18S rRNA confirmed that the RNA was intact.
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Figure 9: Agarose gel electrophoretic pattern of
intact total RNA extracted from cultured 
macrophages by the guanidinium 
thiocyanate-phenol-chloroform method.
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Figure 10: RNA extracted from cultured macrophages
by the lithium chloride method was 
separated by gel electrophoresis. Intact 
28S and 18S rRNA bands are shown.
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A comparison of the electrophoretic analysis of cyto­
plasmic RNA recovered by the method of Gough (1988) and 
the guanidinium thiocyanate technique is depicted in 
figure 11. Using the former method, the results show 
degraded RNA as detected by the absence of visible bands 
and a smear down the gel track. The latter method 
demonstrates the presence of undegraded 28S and 18S rRNA 
bands, which are 5,1 kb and 2,0 kb respectively, and can 
be used as markers (Davis et al, 1986).
4.2.4 RNA blotting
Northern blotting is a technique whereby electro- 
phoretically resolved RNA is transferred from a gel matrix 
to a solid support for the purpose of analyzing specific 
sequences with radiolabelled probes by hybridization. 
Methods have been developed for the transfer of RNA from 
denaturing gels onto nitrocellulose or nylon membranes 
(Thomas, 1980; Meinkoth and Wahl, 1984). RNA preparations 
can also be directly immobilized onto these membranes by 
a process of 'slot-blotting.' However, a prerequisite for 
this technique is the presence of intact RNA which has to 
be confirmed by electrophoresis of the nucleic acid. In 
the current study, RNA was either transferred from an 
agarose gel to Hybond-N (nylon) membrane (Amersham, UK) or 
directly applied to slots on the membrane. Details of the 
procedures were followed according to the manufacturers 
recommendations and with the aid of the manual by Davis 
and colleagues (1986) .
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Figure 11: Ethidium stained agarose gel showing
extracted RNA from cultured macrophages by 
the guanidinium thiocyanate technique (lane 
1) . RNA extracted by the NP40-urea-SDS method 
(lane 2) was significantly degraded as 
evidenced by a smear down the gel track.
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Following electrophoresis, the agarose minigel was rinsed 
twice in 10 x SSC (sodium chloride 1,5 M; sodium citrate 
0,15 M) for 20 minutes to remove excess formaldehyde. The 
gel was placed, with well openings facing down, on a glass 
plate covered with Parafilm plastic. The Hybond-N membrane 
was laid over the gel and any air bubbles were removed by 
rolling a glass stirring rod over the surface. Two sheets 
of filter paper (Whatman 3 MM) were placed on top followed 
by a 5 to 7 cm stack of paper towels, a glass plate and a 
1 kilogram weight to compress the layers. Transfer of the 
RNA was complete after 12 to 15 hours. The transfer effi­
ciency could be checked by staining the gel in ethidium 
bromide (1 jxg/ml) in water. The blot was rinsed in 2 x SSC 
and allowed to air dry. It was then covered with cling 
wrap and exposed to uv light (RNA side down) for 5 minutes 
to ensure covalent retention of the RNA. The blots were 
stored at 4°C ready for hybridization.
In the next procedure, RNA samples were directly 
applied onto Hybond nylon membrane with the aid of a slot 
blot apparatus. The RNA was denatured by incubating 2 to 
5 jug quantities in 20 x SSC (to 50 ( i l) and 50 /xl deionized 
formamide at 55°C for 15 minutes. Two pieces of Whatman 3MM 
paper were first placed in the apparatus and the nylon 
membrane was placed on top. Both were presoaked in 20xSSC. 
A vacuum source was attached and each slot was rinsed with 
100 i l l 20 x SSC. The pretreated RNA samples were added to 
the slots and each well was rinsed with 100 fj.1 20 x SSC. 
The blot was removed, air dried and placed on an ultra­
violet transilluminator for 5 minutes and then kept at 4°C.
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4.3 cDNA PROBES
Single-stranded complimentary DNA (cDNA), possessing 
information contained in a specific mRNA species, is 
constructed by using the enzyme reverse transcriptase. The 
single-stranded DNA is then used to direct the synthesis 
of a complimentary DNA strand. The cDNA sequence is then 
cloned into a vector DNA molecule to provide unlimited 
material for further use. Plasmids, which are small 
circular extrachromosomal molecules, are commonly used as 
carriers and possess genes for properties such as 
antibiotic resistance. This feature can be used as a 
selectable marker for the presence of the cDNA-containing 
plasmid. For the purpose of this study, three cDNA clones 
were used to detect the presence of specific mRNA 
molecules under investigation.
4.3.1 Human g-actin
A human S-actin cDNA, pHF S-AI, was kindly provided 
by Dr. I. Parker, University of Cape Town with permission 
from Dr. L. Kedes, Veterans Administration Medical Centre, 
California. This full length cDNA is inserted in the 
Okayama-Berg cloning expression vector (Gunning et al, 
1983) . The plasmid was obtained in E. coli culture and 
maintained by selection with ampicillin. The insert was 
released with Bam HI as a 1,9-2,1 kb fragment (figure 14).
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4.3.2 Human H-ferritin
The clone for the ferritin H chain has been isolated 
from a human liver cDNA library by screening with a H cDNA 
clone from a human lymphocyte cDNA library (Boyd et al, 
1984 & 1985) . The clone, pHF 16, was provided by Dr. J.W. 
Drysdale, Tufts University School of Medicine, Boston, 
Massachusetts. The H cDNA clone contains a 77-base 5' 
noncoding region, a 552 open reading frame and a 161-base 
3' noncoding region. The cDNA is inserted in the Pst I 
restriction site of the plasmid vector pKT 218 with a 530- 
base deletion (Talmadge et al, 1980) . The plasmid was
obtained in E. coli culture and maintained by tetracycline 
selection. The restriction map is shown in figure 12. The 
cloned DNA was cleaved from the plasmid by digestion with 
Pst I and Rsa I (figure 15). The 430-base H cDNA fragment 
was used to detect specific mRNAs.
4.3.3 Human L-ferritin
The clone, pLF 108, was obtained from Dr. J.W. 
Drysdale. The cDNA clone that contains the entire coding 
region of L ferritin was isolated from a human liver cDNA 
library by screening with oligonucleotides (Boyd et al.
1985). It contains a 151-base 5' noncoding region, a 528 
base coding and a 143-base 3' noncoding region. The insert 
is also situated in the Pst I restriction site of pKT 218 
and was maintained by tetracycline selection in E. coli 
culture. The restriction map is shown in figure 13.
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Figure 12: Partial restriction map of the human H-
ferritin cDNA containing plasmid, pHF 16.
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Figure 13: Partial restriction map of the human L-
ferritin cDNA containing plasmid, pLF 108.
Ill
The insert was released by digestion with the enzymes, Pst 
I and Hind III, and the electrophoretic pattern is shown 
in figure 16. The 224-base fragment was used for probing 
RNA.
4.4 PREPARATION OF PLASMID DNA
4.4.1 Growth and maintenance of bacteria
The S-actin and human H- and L-ferritin cDNA- 
containing plasmids were obtained in E. coli cultures. The 
plasmid vectors contain a gene that encodes a protein that 
confers antibiotic resistance so that E. coli host cells 
can be grown on selective medium. The coli borne inserts 
were either grown in liquid or on agar plates. For liquid 
culture, the usual medium was Luria-Bertani (LB) medium 
(tryptone 1%; yeast extract 0,5%; NaCl 1%) . For solid 
medium, 1,5% of bacteriological agar was added. The medium 
was autoclaved at 120°C for 20 minutes and allowed to cool 
to 60°C. The appropriate antibiotics were added (50 /x/ml 
ampicillin for £-actin and 12,5 ju/ml tetracycline for 
ferritin-subunits) and aliquots were poured onto petri 
dishes for the solid medium. The coli-containing agar 
plates were tightly wrapped in parafilm plastic and stored 
at 4°C for a couple of weeks. For long-term storage, 0,6 ml 
of sterile 50% glycerol solution was added to 1,5 ml 
aliquots of the bacterial culture grown overnight in LB 
medium and stored at -70°C in sterile screw-capped dram 
bottles.
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4.4.2 Isolation and purification techniques
Plasmid DNA was isolated and purified in order to 
provide probe DNA for the hybridization procedures. 
Preparative quantities of the plasmid DNA were extracted 
by alkaline lysis (Maniatis et al, 1982) and further 
purification was achieved by polyethylene glycol precipi­
tation .
Plasmid-containing E. coli cells were grown up in 500 
ml of LB medium containing the appropriate antibiotics. 
The cells were spun down at 5000 g for 10 minutes and the 
supernatant discarded. The cell pellet was washed by 
resuspending in 100 ml ice-cold TSE (Tris-HCL 10 mM, pH 
7,8; EDTA ImM; NaCl lOOmM) and centrifuged again. The 
pellet was then resuspended in 10 ml ice-cold TGE (Tris- 
HCL 25 mM, pH 8; glucose 50mM; EDTA 10 mM) and lysozyme 
was added to 5 mg/ml in order to digest the proteoglycan 
layer of the cell wall. The cell suspension was thoroughly 
mixed and left to stand at room temperature for 10 
minutes. 20 ml of freshly prepared alkaline NS solution 
(sodium hydroxide 200 mM; sodium dodecyl sulphate 1%) was 
added and mixed by gently inverting several times and then 
incubating on ice for 10 minutes. During this process, the 
protoplasts are lysed and total cellular DNA is released. 
The chromosomal DNA is denatured, whereas the plasmid DNA 
is only partially denatured due to its circular form. The 
pH was lowered to approximately 5,0 with 15 ml ice-cold 
potassium acetate (potassium 3 M; acetate 5 M) followed by 
incubation on ice for 10 minutes. This step causes the
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chromosomal DNA to renature randomly producing an 
insoluble protein-DNA-SDS and high molecular weight RNA 
precipitate. The plasmid DNA renatures as well but both 
strands complement properly keeping the plasmid soluble. 
The cell debris and chromosomal DNA were pelleted by 
centrifugation at 76 000 g for 20 minutes at 4°C, leaving 
a supernatant containing predominantly plasmid DNA and low 
molecular weight RNA. The plasmid was further purified by 
polyethylene glycol precipitation. Contaminant RNA was 
removed by the addition of RNAase A to a final concen­
tration of 20 (Li/ml and incubated at 37°C for 20 minutes. To 
remove protein, an equal volume of phenol-chloroform 
(redistilled phenol + 0,1% 8-hydroxy-quinoline equili­
brated with 0,1 M Tris pH 8 and 0,2% S-mercapto-ethanol; 
chloroform:isoamylalcohol 24:1) was added and incubated on 
ice for 10 minutes. The phases were separated by centri­
fugation at 5000 g for 10 minutes. The upper aqueous layer 
was collected and to it was added 1/10 of 1 volume of 3 M 
sodium acetate, pH 7. The plasmid DNA was recovered by the 
addition of 0,6 volumes of isopropanol at -70°C and then 
centrifuged at 12 000 g for 30 minutes. The pellet was 
washed in 70% ethanol and after recentrifugation, it was 
dried in a vacuum centrifuge. The DNA precipitate was 
dissolved in 1,6 ml water and 0,4 ml NaCl (4M) and 2 ml of 
polyethylene glycol (13%) were added. The solution was 
allowed to stand on ice for 10 minutes and after centri­
fugation at 10 000 g, the resultant pellet was washed in 
ethanol, dried and resuspended in TE buffer (Tris-HCL lOmM
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pH 8; EDTA ImM) . All samples were stored at -20°C. The 
plasmid DNA was quantitated by optical density measurement 
at 260nm and the purity assessed by recording the reading 
at 280nm. A ratio of 1,8 to 1,9 (A260 / A280 ) indicated that 
the samples were devoid of protein and phenol. Alterna­
tively, the yield and purity of the plasmid DNA was 
determined by running an aliquot on an agarose minigel 
alongside a series of standard DNA solutions.
4.4.3 Restriction enzyme digestion
The cDNA inserts were released from the plasmids by 
making use of specific restriction endonuclease (RE) 
enzymes in the presence of appropriate buffers. These were 
obtained from Boehringer Mannheim, Mannheim, Germany. As 
discussed in chapter 4.3., pHF S-AI was digested with Bam 
HI; the cDNA was released from pLF 108 using Pst I and
Hind III and a double digest with Pst I and Rsa I was
performed on pHF 16.
The plasmid DNA (1-10/^g) was mixed with water to give 
a volume of 18 /zl in 1,5 ml Eppendorf tubes. Two ij.1 of the 
appropriate buffer and 10-20 units of restriction enzyme 
were added as follows:
For pHF 2-AI : Enzyme Bam HI in buffer B
For pHF 16 : Rsa I in buffer L followed by Pst I with the
addition of 1 ^1 NaCl (2M)
For pLF 108 : Hind III in buffer M followed by Pst I in 
buffer B.
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After incubation at 37°C for 1 hour, the reaction was 
terminated by the addition of 0,5 /zl EDTA (0,5M) . The 
samples were then denatured at 65°C for 5 minutes followed 
by rapid cooling on ice. Two /il of loading buffer 
(glycerol 50% w/v; EDTA ImM; bromophenol blue 0,4% w/v; 
xylene cyanol 0,4% w/v) was added to each tube.
4.4.4 Restriction product gel electrophoresis
The products of the endonuclease digestion were 
resolved by analytical gel electrophoresis in agar. For 
the S-actin and ferritin-subunit probes 0.9% and 1,6% 
agarose minigels were prepared respectively. Low melting 
point agarose (Bio-Rad, California) was dissolved in 
distilled water by heating in a microwave oven. After 
cooling to 60°C, an appropriate amount of TBE buffer (Tris- 
HCL 0.089 M pH 8,0; boric acid 0.089 M; EDTA 2 mM) and 
ethidium bromide (to a final concentration of 0,5 /xg/ml) 
was added. The solution was poured into a mold with gel 
combs in position and allowed to set. After loading of the 
DNA samples, the gel was electrophoresed in TBE running 
buffer at 50V for 3 to 4 hours at 4°C. The samples were run 
alongside molecular weight markers III (Boehringer 
Mannheim, Germany) prepared in the same way as before. The 
gels were photographed on an ultraviolet light source and 
the results are depicted in figures 14, 15 and 16.
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Figure 14: Agarose gel electrophoresis representing 2900
bp and 2000 bp fragments after BAM HI 
digestion of plasmid DNA from pHF S-AI (lane 
3). Lane 1 represents molecular weight size 
markers and lane 2 undigested plasmid DNA.
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Figure 15: Agarose gel electrophoresis of DNA fragments
after PST I and RSA I restriction digestion 
of pHF 16 (lane 3). Lane 1 represents 
molecular weight size markers and lane 2 
undigested plasmid DNA.
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Figure 16: Agarose gel electrophoresis of DNA fragments
after PST I and HIND III digestion of pLF 108 
(lane 2). Lane 1 represents molecular weight 
size markers.
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For recovery of the DNA fragments from the agarose, the 
desired cDNA bands were excised and dissolved in 400 /il of 
distilled water at 65°C for 15 minutes. To 200 /il aliquots 
was added 200 /i 1 of phenol in TE buffer and 200 /il of 
chloroform:isoamylalcohol (24:1). After mixing the 
contents, the tubes were spun at 10 000 g for 20 minutes 
to separate the phases. The upper aqueous layer was 
carefully removed and to it was added NaCl to a final 
concentration of 100 mM. The DNA was concentrated by 
adding 1 volume of isopropanol and chilled to -20°C 
overnight. Each sample was centrifuged at 10 000 g for 20 
minutes at 4°C and the resultant pellets washed in 70% 
ethanol. The tubes were recentrifuged and traces of 
ethanol removed by vacuum drying. The DNA pellet was 
dissolved in 30-50 /il of TE buffer and the amount of 
nucleic acid was quantitated according to Maniatis and 
colleagues (1982) . 1-5 /il of sample was spotted onto
parafilm wrap over a UV source. Appropriate concentrations 
of control DNA were also spotted and 1 /il of TE solution 
containing 2 /il of ethidium bromide was added to each 
spot. The amount of DNA was estimated by comparing the 
fluorescence emitted with that of the standards.
To confirm that the correct cDNA fragments were 
purified, a sample of each probe was electrophoresed with 
size markers in agarose. Figure 17 demonstrates the £- 
actin band (2,0 kb) run on a 0,9% gel and figure 18 shows 
the H-ferritin (430 bp) and L-ferritin (224 bp) fragments 
run on 1,6% agarose gels.
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Figure 17: Ethidium stained 0,9% 
demonstrating the 2,0 
band (lane 2). Lane 1 
weight size markers.
agarose gel 
kb purified S-actin 
represents molecular
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Figure 18: Ethidium stained 1,6% agarose gel of the 430
bp purified H-ferritin fragment (lane 2) and 
224 bp L-ferritin fragment (lane 3). Lane 1 
represents molecular weight size markers.
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4.5 LABELLING PLASMID-DERIVED PROBES
The DNA restriction endonuclease fragments were 
radiolabelled according to a random primer method 
developed by Feinberg and Vogelstein (1983) . In this 
method hexanucleotides of a random sequence are used to 
prime DNA synthesis on denatured template DNA. The Klenow 
fragment of DNA polymerase I is used to synthesize a new 
complementary DNA strand from the 3'-hydroxyl termini of 
the hexamer primer. 32P-labelled and unlabelled deoxy- 
nucleoside triphosphates present in the reaction are 
incorporated into the newly synthesized complementary DNA 
strand. A commercially available kit obtained from 
Boehringer Mannheim (Mannheim, Germany) was used.
The cDNA to be labelled (1 to 9 ^1, 20-200 ng in TE 
buffer) was denatured by heating to 100°C for 2 minutes in 
a boiling water bath and then chilled on ice. To this was 
added an appropriate volume of each reagent in the 
following order: 3 /il of nucleotide mix (dATP, dGTP,
dTTP) ; 2 f i l of reaction mixture (random hexamers in
reaction buffer) ; 5 f i l of a-32P dCTP (50 piCi at 3000
Ci/mmol, Amersham, UK) and 1 /zl of Klenow enzyme. The 
contents were incubated at 37°C for 30 to 90 minutes. The 
reaction was terminated by the addition of 2 /xl 2,3 mol/1 
EDTA (pH 8) and/or by heating to 65°C for 10 minutes.
The efficiency of labelling was monitored by 
determining the percentage incorporation of radiolabel 
into the newly synthesized DNA. The most commonly used 
technique involves the incorporation of radioactivity into
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acid-insoluble material by trichloroacetic acid (TCA) 
precipitation. For this purpose, 1 /xl of reaction mixture 
was diluted into 100 to 200 /xl of water containing 50 /xl 
carrier DNA (at 1 mg/ml) . 50 /xl of this sample was spotted 
onto Whatman GFC glass microfibre filter discs contained 
in scintillation vials. This gave the total number of 
counts in the sample. To an equal volume of the sample was 
added 2 ml ice-cold 10% TCA. The mixture was vortexed and 
kept on ice for 10 to 15 minutes to allow co-precipitation 
of the labelled and carrier DNA. The precipitated DNA was 
collected on glass microfibre filter discs by vacuum 
filtration and then washed well with 10% TCA. All the 
filter discs were dried thoroughly and after the addition 
of 10 ml Scintillation fluid to each, the radioactivity 
was determined by liquid scintillation counting. The 
percentage incorporation was calculated as follows:
% incorporation = precipitated counts x 100
total counts
The amount of newly synthesized DNA (ng) was determined 
according to the formula:
total number of uCi added x 13,2 x % incorporation 
specific activity of dCTP (Ci/mmol)
uCi dCTP (50/xCi) x 13.3 x % incorporation 
specific activity of dCTP (3000 Ci/mmol)
The specific activity in dpm//xg was determined as follows:
incorporated radioactivity in dpm 
input DNA + newly synthesized DNA
IjlCi dCTP (50uCi) x 2,2xl04 x % incorporation x 103 
input DNA + newly synthesized DNA
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A specific activity of 0,7 x 109 to 1,8 x 109 dpm//ig was 
achieved corresponding to 71% incorporation and 65% 
incorporation respectively. The removal of unincorporated 
label by gel filtration or selective precipitation was 
found not to be necessary as the incorporation exceeded 
60%.
4.6 HYBRIDIZATION
4.6.1 Introduction
Molecular hybridization is the formation of double­
stranded nucleic acid molecules by sequence specific base 
pairing of complementary single strands (Britten and 
Davidson, 1985) . Electrophoretically separated RNA species 
that are transferred to solid supports (blots) are 
amenable to this technique. A radiolabelled cDNA probe is 
then capable of hybridizing to complementary sequences 
found among the molecules bound to the solid support. The 
association and dissociation kinetics governing comple­
mentary hydrogen bonding between the base pairs of nucleic 
acids are influenced by many factors. Among the factors 
influencing this equilibrium are concentration, tempera­
ture and salt concentration of the hybridization buffer 
and the presence of rate enhancers, helix destabilizers 
and blocking agents. The quality of the results is further 
affected by probe related variables such as probe specific 
activity, probe concentration and probe length.
In this section, northern blots and slot blots 
containing transferred RNA were hybridized by modification
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of a protocol described by the manufacturers of Hybond N 
membrane (Amersham, UK) followed by quantitative auto­
radiography to identify and measure the amount of RNA 
species of interest.
4.6.2 Conditions for hybridization
The hybridization procedure can be divided into 3 
steps : prehybridization, hybridization with labelled 
probe and washing. In the prehybridization step the blots 
are incubated in a solution which pre-coats all the sites 
which would bind the probe non-specifically. The northern 
blots and slot blots were prehybridized in heat seal bags 
at 42°C for 4 to 5 hours in a constant shaking water bath. 
5 to 20 ml of prehybridization solution was used for each 
bag. The solution contained the following : 6,25 ml 20x 
SSPE (3,6 M NaCl; 0,2 M sodium phosphate, pH 7,7; 0,02 M 
EDTA) ; 12,5 ml deionized formamide; 1,25 ml lOOx Denhardts 
solution (2% bovine serum albumin [w/v], 2% Ficoll [w/v], 
2% polyvinyl pyrollidone [w/v]); 3,75 ml water; 200 /xl 
(2mg) denatured herring sperm DNA and 1,25 ml 10% (w/v) 
sodium dodecyl sulphate (SDS).
Following incubation, the prehybridization buffer was 
removed and replaced with 5 to 15 ml (per bag) of hybri­
dization buffer containing the denatured labelled cDNA 
probe. 20 /xl of the labelled reaction mixture was diluted 
to 50 /xl with water and then denatured at 100°C for 2 
minutes and chilled on ice. An aliquot of 10 /xl was added 
to each northern blot and 10 to 15 /xl to each slot blot.
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The hybridization solution was made up by adding in the 
following order : 6,25 ml 20x SSPE; 12,5 ml deionized
formamide; 1,25 ml Denhardts solution; 2 ml water; 
denatured labelled cDNA probe and 4% (w/v) polyethylene
glycol (MW 8000) . The blots were hybridized in a shaking 
water bath at 42°C for at least 12 hours.
Following hybridization the blots were washed. For 
the detection of H- and L-ferritin mRNA species in human 
macrophages using ferritin cDNA probes, the blots were 
washed as follows: In the first wash, the blots were 
incubated in 2x SSPE and 0,1% (w/v) SDS at 42°C for 15
minutes. The procedure was repeated once. The solution was 
replaced with lx SSPE and 0,1% (w/v) SDS and incubated at 
42°C for 30 minutes. This was followed by a high stringency 
wash in 0,lx SSC (15 mM NaCl; 1,5 mM sodium citrate) with 
0,1% (w/v) SDS at room temperature for 15 minutes.
When human macrophage RNA was probed with the human £- 
actin probe, the washes were carried out in the following 
order:
WASH 1: Each blot was washed briefly at 42°C in 2x SSC 
(0,3 M NaCl; 0,03 M sodium citrate) ;
WASH 2: 2x SSC with 0,1% SDS for 10 minutes at room 
temperature ;
WASH 3: Repeat wash 2 ;
WASH 4: lx SSC with 0,1% SDS at 65°C for 15 minutes ;
WASH 5: 0,lx SSC with 0,1% SDS at 65°C for 10 minutes.
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The blots were air dried and wrapped in cling film. The 
location of radioactivity on the blots was detected by 
autoradiography. The blots were placed in the dark under 
preflashed Kodak XAR-5 film enclosed in an X-ray film 
cassette with intensifying screens. The use of inten­
sifying screens and preflashed film ensures maximum 
sensitivity. The film was exposed at -70°C for 36 to 48 
hours and developed in an automated developer. Figure 19 
demonstrates autoradiographs of northern blots of RNA 
extracted from 8 day cultured macrophages that were probed 
with human H- and L-ferritin and S-actin probes.
4.6.3 Quantitation of autoradiographs
The amount of radioactivity bound to the slot blots 
was quantitated by densitometric scanning of the auto­
radiographs using a video densitometer and image analyzer 
(Biomed Instruments, Fullerton, California).
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Figure 19: Autoradiogaphs of northern blots of human
macrophage RNA probed for E-actin (lane 1), 
H-ferritin (lane 2) and L-ferritin (lane 3) 
confirming probe specificity. Relative 
positions of 28S and 18S rRNA are indicated 
by arrowheads.
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SECTION 3
CHAPTER 5
FERRITIN MESSENGER RNA IN MACROPHAGES
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5.1 INTRODUCTION
The observation that the reticuloendothelial cells 
contain little iron in HLA-linked haemochromatosis has led 
many investigators to believe that an abnormality in 
ferritin metabolism may be responsible, leading to reduced 
iron storage within these cells and increased delivery of 
iron to the plasma. The introduction to this chapter 
focuses mainly on the regulation of ferritin messenger RNA 
(mRNA) in relation to iron and ultimately the synthesis of 
ferritin in the setting of the RES.
Cells of the mononuclear-phagocyte system play a 
pivotal role in the storage of iron and have been shown to 
contain significant amounts of ferritin (Summers et al, 
1975). Variations in the proportion of H- to L- subunits 
within these cells have been reported. In normal RE iron 
metabolism, it is generally supposed that macrophages 
accumulate L-rich isoferritins (Harrison, 1986; Worrall 
and Worwood, 1991; Raha-Chowdhury et al. 1993) to
accomodate larger amounts of iron for long term iron 
storage (Bomford et al, 1978; Theil, 1987). In contrast, 
monocytes are relatively rich in H-type subunits (Powell 
et al, 1975a; Jones et al. 1983) and it has been suggested 
that they are involved in recycling of iron to the inter­
mediate labile iron pool for metabolic processes (Jacobs, 
1985; Pattanapanyasat, 1989). Worrall and Worwood (1991)
were not able to demonstrate a difference in the increase 
of H- and L-type ferritin protein subunits in response to 
iron between normal subjects and haemochromatotic 
patients.
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Ferritin synthesis can be regulated either at a 
transcriptional or a translational level or both [section 
1, chapter 1.3.6] . The characteristics of ferritin mRNA 
during the in vitro maturation of human monocytes to 
macrophages were investigated by Testa and co-workers 
(1989). The authors documented a considerable increase in 
mRNA for both H and L ferritin during monocyte incubation 
in vitro for 8 days. However, the addition of iron as 
ferric ammonium citrate to the cultures stimulated 
ferritin synthesis but only slightly enhanced H- and L- 
ferritin mRNA levels. The effect observed during the in 
vitro maturation of monocytes could be related to 
transcriptional activation whereas upon iron stimulation 
a translational mechanism is mainly involved.
It is clear that the IRE and IRP play an important role in 
the maintenance of intracellular iron homeostasis by 
coordinately regulating the translation of the mRNAs for 
ferritin and the transferrin receptor [section 1, chapter 
1.3.6.2] . This mechanism has recently been shown to be 
intact in the gut in haemochromatosis (Pietrangelo et al. 
1993) . The distribution of iron in gut and RE cells in 
haemochromatosis (Brink et al, 1976) suggests that these 
cells share common intracellular iron mechanisms, at least 
with respect to ferritin.
With regard to overall ferritin synthesis in RE cells 
in haemochromatosis, Saab and colleagues (1986), observed 
that monocyte ferritin content was decreased in patients 
with haemochromatosis. However, a number of investigators
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have revealed no differences in ferritin synthesis and 
ferritin content in monocytes between patients and normal 
subjects (Jacobs and Summers, 1981; Bassett et al. 1982). 
It should be noted that these studies were conducted 
mainly on monocytes and therefore may not be an accurate 
reflection of ferritin metabolism in macrophages. 
Recently, Gordeuk and co-workers (1992) showed that 
cultured monocytes from haemochromatotic patients released 
decreased amounts of TNF-O! compared with normal cells. The 
author suggested that ferritin synthesis may in fact be 
impaired within cells of the mononuclear phagocyte system 
of haemochromatotics, either by decreased transcription of 
mRNA or reduced translational activity. It is more likely 
that the TNE-a gene located close to the HLA locus on 
chromosome 6 (Spies et al. 1986), the gene for hereditary 
haemochromatosis, may play a role in the pathogenesis of 
the disease rather than the postulation that a mutation in 
the IRP (Kuhn, 1991), coded on chromosome 9 (Hentze et al, 
1989a) , could be related to the dysfunction in iron 
metabolism in haemochromatosis.
It is apparent that many factors affecting ferritin 
biosynthesis have to be considered carefully when devising 
a suitable model of iron metabolism. With regard to mono­
nuclear phagocytes, the type of cell (monocyte or macro­
phage) , metabolic state and iron status and source of iron 
re amongst the factors that appear to be important.
The current study aimed to examine the hypothesis 
that an abnormality in reticuloendothelial ferritin
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synthesis exists in haemochromatosis. To this end, the 
levels of ferritin mRNA in response to iron were investi­
gated in normal and haemochromatotic macrophages cultured 
in vitro. The methodologies described in chapters 2.2 and 
4 were applied to this study.
5.2 SUBJECTS AND METHODS
300 ml of blood was collected into citrate from
healthy adult volunteers (with informed consent) and
during therapeutic venesection from patients with
haemochromatosis. The patients, who had excess iron
removed previously, were only bled occasionally during 
monitoring.
Mononuclear cells were separated by centrifugation 
over Ficoll-hypaque followed by adherence to tissue 
culture petri dishes according to methods described in 
section 2, chapter 2.2. Each 35mm diameter petri dish 
contained 3 x 10s cells in 2,5 ml BMESS with 10% autologous 
serum and antibiotics. The cells were incubated at 37°C in 
a 5% C02 incubator for 8 days. Cell viability ranged from 
85 to 100% as determined by the trypan blue exclusion 
test. The adherent cells were characterized and more than 
90% demonstrated non-specific esterase activity and 
phagocytosed yeast particles. All experiments were per­
formed on the eighth day of culture as follows :
After the non-adherent cell population and culture medium 
were decanted, the petri dishes were washed 3 times with 
PBS. Ten petri dishes were set up for each time interval
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to be studied. To each dish was added 2 ml RPMI and 10% 
fetal calf serum and the cells were preincubated for 1 
hour at 37°C. Ferric ammonium citrate was added to each 
culture dish to give a final concentration of added iron 
of 200 /iM. The fetal calf serum contributed an additional 
3 jtxM of iron. Ferric ammonium citrate has been shown to 
enhance ferritin synthesis (Bassett et al. 1982) and 
ferritin mRNA (Testa et al. 1989) in both normal and 
haemochromatotic cultured monocytes. Control dishes 
containing cells and RPMI medium but no added iron were 
also included. The cells were incubated at 37°C under 5% 
C02 and 95% humidity for various periods up to 8 hours.
At 0, 4, 6, and 8 hours after incubation, the medium 
was removed and each dish was washed 3 times with PBS. 
Total RNA was prepared by extraction from the macrophages 
at various times by the guanidinium isothiocyanate phenol- 
chloroform technique [chapter 4.2.1] . The contents of 10 
dishes (for each time interval) were pooled into 1 Eppen- 
dorf tube and each RNA specimen was assessed spectrophoto- 
metrically. The RNA integrity was evaluated by electro­
phoresis in 1,5% formaldehyde agarose gels. For slot blot 
analysis, 5 fig of RNA were added to each slot and the 
blots were hybridized with 32P-labelled human H- and L- 
ferritin subunit probes and the human S-actin probe. After 
washing, the blots were autoradiographed at -70°C for 48 
hours. For northern blot analysis (to confirm probe 
specificity), 5 /ig of total RNA was run on 1,5% 
formaldehyde gels, transferred onto Hybond nylon membrane
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by northern blotting, hybridized and exposed as for the 
slot blots. The intensity of radioactive bands on the slot 
blots was analyzed by densitometric scanning using a video 
densitometer and image analyzer (Biomed, California, USA). 
The amount of mRNA was quantitated by determining the 
areas under the peaks obtained for each slot. The control 
(0 hour) time points in each experiment were normalized to 
1. The final data were expressed as the relative amounts 
of H- and L- ferritin mRNA to the constitutively expressed 
S-actin mRNA levels.
5.3 RESULTS
To evaluate the effect of iron on ferritin mRNA 
levels, 8 day cultured macrophages from normal subjects 
and haemochromatotic patients were incubated in the 
presence of ferric ammonium citrate for up to 8 hours. 
Autoradiographs of representative slot blots containing 
RNA probed with S-actin (used as a constitutively ex­
pressed control), H-ferritin and L-ferritin subunit probes 
from a normal subject and a haemochromatotic patient are 
shown in figures 20, 21 and 22, respectively. In each 
figure autoradiographs of northern blots demonstrate 
integrity of the corresponding message.
The slot blots for each patient and probe used were 
scanned quantitatively by densitometry and the resultant 
peaks are depicted in figures 23 and 24.
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B-ACTIN
NORMAL HOT
Figure 20: Autoradiographs of slot blots of RNA from
macrophages cultured in the presence of iron 
for various time intervals of 1 normal and 1 
haemochromatotic subject (HCT) probed for fi- 
actin mRNA. The lower panel demonstrates a 
northern blot showing probe specificity.
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H-FERRITIN
NORMAL HCT
Figure 21: Autoradiographs of slot blots of RNA from
macrophages cultured in the presence of iron 
for various time intervals of 1 normal and 1 
haemochromatotic subject (HCT) probed for H- 
ferritin mRNA. The lower panel demonstrates 
a northern blot confirming probe specificity.
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L-FERRITIN
Figure 22: Autoradiographs of slot blots of RNA from
macrophages cultured in the presence of iron 
for various time intervals of 1 normal and 1 
haemochromatotic subject (HCT) probed for L- 
ferritin mRNA. The lower panel demonstrates 
a northern blot showing probe specificity.
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Figure 23: Slot blot analysis by densitometric
of normal macrophage RNA probed with 
H-ferritin and L-ferritin.
scanning
E-actin,
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Figure 24: Slot blot analysis by densitometric scanning
of HCT macrophage RNA probed with S-actin, H- 
ferritin and L-ferritin.
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The area under each peak was calculated by computer 
analysis and the values for the H-ferritin to S-actin mRNA 
ratios and the L-ferritin to E-actin ratios are shown in 
Tables IV and V, respectively. (The values for H- and L- 
ferritin mRNAs were expressed relative to S-actin mRNA to 
account for any variation in the amount of RNA added to 
each slot) . The calculated ratios of ferritin mRNA to S- 
actin mRNA signals (values at t=0 normalized to 1) were 
plotted against time of incubation with iron and the 
results are depicted in figures 25 and 26. Both normal and 
haemochromatotic cells show an increase in H and L mRNA to 
S-actin but the patterns are different. In normal macro­
phages (figure 25) the ratio of H-ferritin mRNA to E-actin 
mRNA peaked after 6 hours of incubation with iron. In 
haemochromatotic macrophages the peak was at 4 hours and 
was about half that seen with normal macrophages. There­
after the levels returned to baseline values for both 
study groups. This was confirmed when the incubation time 
was extended to 24 hours (not shown on graph). A greater 
increase in L-ferritin mRNA relative to E-actin mRNA at 6 
hours was also observed in normal macrophages compared 
with haemochromatotic macrophages (figure 26). No changes 
in the ratios of L-ferritin to H-ferritin mRNA were noted 
in cells from either normal subjects or patients with 
haemochromatosis.
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TABLE IV ; Ratios of H-ferritin mRNA to S-actin mRNA for
1 normal and 1 haemochromatotic (HCT) subject.
Time (hours) Normal HCT
0 2.88 1.16
4 2.24 2.90
6 12.84 2.11
8 7.17 1.48
TABLE V ; Ratios of L-ferritin mRNA to S-actin mRNA for 
1 normal and 1 haemochromatotic (HCT) subject.
Time (hours) Normal HCT
0 2.90 1.96
4 2.27 4.37
6 11.99 3.08
8 6.09 2.65
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Figure 2 5 : The ratios of H-ferritin mRNA to S-actin mRNA
with respect to time of incubation of 
cultured macrophages from 1 normal (o) and 1 
haemochromatotic subject (•) with iron. 
Quantitative analyses of all densitometric 
data obtained from Table IV.
(Values have been corrected such that the 
densities at time 0=1)
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Figure 26: The ratios of L-ferritin mRNA to S-actin mRNA
with respect to time of incubation of 
cultured macrophages from 1 normal (o) and 1 
haemochromatotic subject (•) with iron. 
Quantitative analyses of all densitometric 
data obtained from Table V.
(Values have been corrected such that the 
densities at time 0=1)
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5.4 DISCUSSION
RE cells in hereditary haemochromatosis appear to be 
spared in terms of iron accumulation (Valberg et al, 1975; 
Brink et al. 1976; McClaren, 1989). It has been proposed 
that these cells are unable to synthesize ferritin ade­
quately resulting in a failure to retain iron normally 
causing enhanced absorption and iron deposition in paren­
chymal cells. Because of this, the present is vitro study 
aimed to investigate whether macrophage ferritin mRNA 
levels in response to iron administration differed between 
normal subjects and haemochromatotic patients.
Firstly, the level of both H- and L-ferritin mRNA is 
seen to rise relative to S-actin for both normal and 
haemochromatotic cells. The pattern of change for the two 
types of cells appear to be different in that the haemo­
chromatotic cells show an approximate 2 fold increase by 
4 hours, followed by a decrease to approximate the initial 
level at 8 hours, while the normal cells do not show an 
increase for 4 hours, then a large (4 to 5 fold) increase 
by 6 hours which falls by 8 hours. The study by Testa and 
co-workers (1989) demonstrated a marked increase in H- and 
L-ferritin mRNA in monocytes cultured for 8 days compared 
with fresh monocytes. In the present study, only 8 day 
macrophages were studied and therefore no comparison 
between ferritin mRNAs in normal and haemochromatotic 
cells can be made on the changes during the in vitro 
maturation process. The same authors also observed a 
slight increase in ferritin mRNA in response to iron but
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far greater increases in the total ferritin content, 
implying that a translational mechanism may be involved. 
The iron induced increase in ferritin mRNAs noted in the 
current study may have occurred as a result of an enhanced 
transcription and/or increased stability of the tran­
scripts. It is possible that the cells from both study 
groups were relatively deprived of iron after 8 days in 
culture and transcriptional activation resulted in the 
synthesis of more ferritin subunit mRNAs for iron storage 
for intracellular use. It should however be noted that a 
possible role of translational activation was not consi­
dered here, since the total ferritin content was not 
determined.
The greater increase in H- and L-ferritin mRNA levels 
observed in normal macrophages compared with cells from 
patients with haemochromatosis needs to be explained. The 
addition of iron salts to monocyte-macrophage cultures 
(from healthy subjects) has been shown to moderately 
enhance the levels of ferritin mRNA subunits (Testa et al,
1989). This mechanism whereby iron induces ferritin 
expression appears to be less effective in haemo- 
chromatotic cells. It is possible that haemochromatotic 
macrophages fail to respond normally to iron given in this 
form. However, previous workers have demonstrated normal 
ferritin protein synthesis in macrophages in response to 
iron presented as ferric ammonium citrate (Bassett et al. 
1982; Testa £t al, 1989). In the previous study on 
transferrin-iron-macrophage interactions (section 2,
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chapter 3), the uptake of iron from transferrin by 
haemochromatotic macrophages was lower than by normal 
macrophages. This may be explained by an increased release 
of iron by haemochromatotic macrophages and hence lower 
intracellular iron levels. If the same mechanism applies 
when iron is presented as ferric ammonium citrate, the 
difference in ferritin mRNA levels could also be explained 
on the basis of lower intracellular iron causing less 
ferritin gene expression in haemochromatotic macrophages. 
The abnormal behaviour of the RE cell should be paralleled 
to that of the intestinal mucosal cell since the latter is 
also relatively spared of iron (Brink et al. 1976) . Inso­
far as the gut is concerned, McClaren and co-workers 
(1991) showed that an increased mucosal iron transfer rate 
was the major determinant of increased iron absorption in 
hereditary haemochromatosis. In another study performed on 
duodenal mucosal cells of patients with haemochromatosis, 
reduced levels of ferritin subunit mRNAs and a lack of 
transferrin receptor down-regulation was postulated to 
occur secondary to lower mucosal iron content caused by 
accelerated release of cellular iron (Pietrangelo et al, 
1992). It therefore appears that the gut and RE cells may 
share a common defect of impaired iron release in HLA- 
linked haemochromatosis.
The present study is only concerned with measuring 
the early gene products (ferritin subunit mRNAs). In order 
to comment on ferritin synthesis as a whole, the amount of 
the final protein product, ferritin, the distribution of
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free to polysome-bound mRNA and the rate of ferritin mRNA 
turnover would need to have been measured, but was beyond 
the scope of this study. Furthermore, a larger study group 
would have to be investigated to confirm the current 
findings. The refinement and application of molecular 
biological techniques to this study has however been a 
most valuable learning experience.
6. CONCLUSION
HLA-linked haemochromatosis is associated with an 
altered distribution of storage iron. The RE cells and 
intestinal mucosal cells release more iron than is needed. 
It is known that RE cells derive most of their iron from 
senescent red blood cells and that iron delivered by 
transferrin represents a small fraction of RE turnover. In 
the present study, the uptake of transferrin and trans­
ferrin iron was determined in cultured macrophages from 
normal subjects and patients with haemochromatosis. An 
increased transferrin uptake was noted in macrophages from 
patients with haemochromatosis compared to normal macro­
phages. However, the uptake of iron from transferrin was 
notably less in haemochromatotic macrophages. This could 
be explained by an inability of RE cells to store iron as 
ferritin in haemochromatosis. It is also possible that the 
observed response may relate to an accelerated release of 
iron to the extracellular environment leading to lower 
intracellular iron levels.
It is known that ferritin plays a central role in the 
storage of iron and that its synthesis is regulated by
149
iron, in vitro studies were performed to evaluate the 
effect of iron on the levels of ferritin subunit mRNAs in 
normal and haemochromatotic cultured macrophages. The 
expression of both heavy and light ferritin chains at RNA 
level was greater in normal macrophages compared to haemo­
chromatotic macrophages. The findings suggest a primary 
defect in ferritin mRNA expression in response to iron in 
RE cells from patients with haemochromatosis. Alterna­
tively, the reduced levels of ferritin mRNA transcripts 
are presumably secondary to decreased cellular iron 
content attributable to enhanced cellular iron release. 
The present study did not address the effect of iron on 
post-transcriptional processes, the rate of ferritin mRNA 
turnover and the amount of the final gene product, 
ferritin. This may provide further insight into the theory 
that ferritin synthesis is impaired in mononuclear phago­
cytes in hereditary haemochromatosis.
On the basis of the present study one might specu­
late, therefore, that the paucity of iron observed in the 
RE cells in haemochromatosis may relate to increased iron 
release from the cells. The cells may then respond to an 
apparent iron deficient state by lowering ferritin gene 
expression as ferritin mRNA. The hypothesis may not be 
mutually exclusive if it is assumed that the RE cells and 
intestinal mucosal cells behave in the same way. A common 
defect in the cellular and molecular mechanisms in either 
iron storage or the release of increased amounts of iron 
to the circulation may be postulated to be central to the 
disordered iron metabolism of HLA-linked haemochromatosis.
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